0001493152-24-020652.txt : 20240520 0001493152-24-020652.hdr.sgml : 20240520 20240520154907 ACCESSION NUMBER: 0001493152-24-020652 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APPYEA, INC CENTRAL INDEX KEY: 0001568969 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371] ORGANIZATION NAME: 06 Technology IRS NUMBER: 461496846 STATE OF INCORPORATION: SD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55403 FILM NUMBER: 24964219 BUSINESS ADDRESS: STREET 1: 16 NATAN ALTERMAN ST CITY: GAN YAVNE STATE: L3 ZIP: 7085118 BUSINESS PHONE: (800) 674-3561 MAIL ADDRESS: STREET 1: 447 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10013 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

MARK ONE

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the Quarterly Period ended March 31, 2024; or

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from ________ to ________

Commission File Number: 000-55403

APPYEA, Inc.

(Exact name of registrant as specified in its charter)

Nevada

46-1496846

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

16 Natan Alterman St, Gan Yavne, Israel
(Address of principal executive offices)		Zip Code

(800) 674-3561

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 20, 2024, there were outstanding 451,113,064 shares of the registrant’s common stock, par value $0.0001 per share.

APPYEA, INC.

Form 10-Q

March 31, 2024

	Page

PART I — FINANCIAL INFORMATION

Item 1 – Unaudited Condensed Consolidated Financial Statements	4

Condensed Consolidated Balance Sheets – March 31, 2024 (unaudited) and December 31, 2022	5

Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023 (unaudited)	6

Condensed Consolidated Statement of Changes in Stockholders’ Equity (deficit) for the three months ended March 31, 2024 and 2023 (unaudited)	7

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (unaudited)	8

Notes to Unaudited Condensed Consolidated Financial Statements	9-16

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations	17

Item 3 – Quantitative and Qualitative Disclosures About Market Risk	23

Item 4 – Controls and Procedures	23

PART II — OTHER INFORMATION	24

Item 1 – Legal Proceedings	24

Item 1A – Risk Factors	25

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds	25

Item 3 – Defaults upon Senior Securities	25

Item 4 – Mine Safety Disclosures	25

Item 5 – Other Information	25

Item 6 – Exhibits	25

Exhibit Index	25

SIGNATURES	26

APPYEA INC. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF MARCH 31, 2024

APPYEA INC. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF MARCH 31, 2024

INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

	Page

Condensed Consolidated Balance Sheets	5

Condensed Consolidated Statements of Operations	6

Condensed Consolidated Statements of Changes in Deficiency	7

Condensed Consolidated Statements of Cash Flows	8

Notes to the Condensed Consolidated Financial Statements	9-16

APPYEA INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands)

	March 31, 2024			December 31, 2023
	Unaudited			Audited
ASSETS
Current assets
Cash and cash equivalents		373			222
Accounts receivables		1			-
Other accounts receivables		30			42
Inventory		14			14
Total current assets		418			278

Non-current assets
Property and equipment, net		2			3
Intangible assets, net		238			193
Total non-current asset		240			196

Total assets		658			474

LIABILITIES AND DEFICIENCY
Current liabilities
Trade payables		24			51
Other accounts payable		679			694
Short-term loans from related party		79			79
Convertible loans at amortized cost		811			796
Convertible loans – At fair value		2,160			1,203
Financial liability at fair value		72			204
Total current liabilities		3,825			3,027
Total liabilities		3,825			3,027

DEFICIENCY
AppYea Inc. Stockholders’ Deficiency:
Convertible preferred stock, $0.0001 par value		-			-
Common stock, $0.0001 par value		41			31
Stock payables		657			559
Additional Paid in Capital		3,719			3,197
Accumulated deficit		(7,570	)		(6,326	)
Total AppYea Inc. stockholders’ deficiency		(3,153	)		(2,539	)
Non-controlling interests		(14	)		(14	)

Total Deficiency		(3,167	)		(2,553	)

Total liabilities and deficiency		658			474

The accompanying notes are an integral part of the financial statements.

APPYEA INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(U.S. dollars in thousands)

	2024			2023
	For the three months ended March 31,
	2024			2023
	Unaudited			Unaudited

Sales		13			-
Cost of sales		(3	)		-
Gross profit		10			-

Research and development expenses		(60	)		(9	)
Sales and marketing		(54	)		-
General and administrative expenses		(294	)		(427	)

Operating loss		(398	)		(436	)

Change in fair value of convertible loans and warrant liability		(824	)		166

Financial income (expenses), net		(22	)		(19	)

Loss before income tax benefit		(1,244	)		(289	)

Income tax benefit		-

Net loss		(1,244	)		(289	)

Net loss attributable to AppYea Inc.		(1,244	)		(289	)

Net Loss per Common Share:

Basic and Diluted		(0.003	)		(0.001	)

Weighted Average number of Common Shares Outstanding basic and diluted		380,266,957			225,248,108

The accompanying notes are an integral part of the financial statements.

APPYEA INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN DEFICIENCY

(U.S. dollars in thousands except share data)

	Number			Amount		Number		Amount		Capital			Payables			Deficit			Total			interests			Equity
	Preferred Stock					Common Stock				Additional Paid in			Shares to be			Accumulated						Non-controlling			Total
	Number			Amount		Number		Amount		Capital			issued			Deficit			Total			interests			Equity
	Unaudited
Balance as of January 1, 2024		258,745			-		328,836,657		31		3,197			559			(6,326	)		(2,539	)		(14	)		(2,553	)

Share based Compensation		-			-		-		-		147			-			-			147			-			147
Net loss		-			-		-		-		-			-			(1,244	)		(1,244	)		-			(1,244	)
Shares to be issued
Shares to be issued to service providers		-					-		-		-			25			-			25			-			25
Issuance of Shares		-					60,143,100		6		379			(2	)		-			383			-			383
Shares to be issued to investors							-		-		-			75			-			75			-			75
Options exercise							500,000		-		-			-			-			-			-			-
Share issuance upon conversion of Preferred stock		(28,147	)		-		42,217,500		4		(4	)		-			-			-			-			-

Balance as of March 31, 2024		230,598			-		431,697,257		41		3,719			657			(7,570	)		(3,153	)		(14	)		(3,167	)

	Preferred Stock				Common Stock				Additional Paid in		Shares to be		Accumulated						Non-controlling			Total
	Number		Amount		Number		Amount		Capital		issued		Deficit			Total			interests			Equity
	Unaudited
Balance as of January 1, 2023		300,000				220,930,798		21		1,912		27		(4,509	)		(2,549	)		(14	)		(2,563	)
Balance		300,000				220,930,798		21		1,912		27		(4,509	)		(2,549	)		(14	)		(2,563	)

Share based Compensation		-		-		-		-		279		-		-			279			-			279
Net loss		-		-		-		-		-		-		(289	)		(289	)		-			(289	)
Shares to be issued		-		-		-		-		-		1		-			1			-			1
Share issuance upon conversion of Convertible notes.		-		-		8,634,616		1		160		-		-			161			-			161

Balance as of March 31, 2023		300,000		-		229,565,414		22		2,351		28		(4,798	)		(2,397	)		(14	)		(2,411	)
Balance		300,000		-		229,565,414		22		2,351		28		(4,798	)		(2,397	)		(14	)		(2,411	)

The accompanying notes are an integral part of the financial statements.

APPYEA INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands)

	2024			2023
	For The Three Months Ended March 31,
	2024			2023
	Unaudited
Cash flows from operating activities:
Net loss		(1,244	)		(289	)
Adjustments to reconcile loss to net cash used in operating activities:
Depreciation and amortization		6			6
Share based compensation		172			279
Change in fair value of convertible loans and warrant liability		824			(147	)
Financial expenses, net		14			-

Changes in operating assets and liabilities:
Other current assets		11			1
Accounts payables		(24	)		74
Accounts payables – related party		(16	)		(21	)
Net cash used in operating activities		(257	)		(97	)

Cash flows from investing activities:
Research and development expenses capitalization		(50	)		-
Net cash used in investing activities		(50	)		-

Cash flows from financing activities:
Proceeds from issuance of Common Stock		381			-
Proceeds from convertible Note received, net of issuance expenses		-			141
Proceeds on account of Shares to be issued		75			-
Net cash provided by financing activities		456			141

Foreign exchange on Cash and cash equivalents		3			(4	)
Change in cash and cash equivalents		152			40
Cash and cash equivalents at beginning of period		222			60

Cash and cash equivalents at end of period		373			100

The accompanying notes are an integral part of the financial statements.

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 1 - GENERAL

AppYea, Inc. (“AppYea”, “the Company”, “we” or “us”) was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and no operating history. On November 1, 2021 the Company was redomiciled in the State of Nevada.

The Company’s common stock is traded on the OTC Markets, OTCQB tier, under the symbol “APYP”.

SleepX LTD is a company formed under the laws of the State of Israel and a wholly owned subsidiary of the Company (“SleepX”). SleepX is a research and development company that has developed a proprietary product for monitoring and treating sleep apnea and snoring. The technology is protected by several international patents and the Company started serial production in 2023. Subject to raising working capital, of which no assurance can be provided, the Company intends to focus on further development and commercialization of its products.

SleepX has incorporated, together with an unrelated third party, a privately held company under the laws of the State of Israel named Ta-nooma Ltd. (“Ta-nooma”). Ta-nooma has developed sleeping monitoring technology for which patent applications were filed and has no revenue from operations. Since its incorporation and as of the financial statements date, Sleepx holds 66.7% of the voting interest of Ta-nooma.

Strategic Development

The company flagship product is AppySleep – A Biofeedback snoring treatment wristband, combined with the AppySleep App (“AppySleep”).

The AppySleep product is currently in serial manufacturing and commercial stage.

Financial position

The financial statements are presented on a going-concern basis. To date, the Company has not generated any significant revenues, suffered recurring losses from operations, incurred negative cash flows from operating activities, and is dependent upon external sources for financing its operations. As of March 31, 2024, the Company had an accumulated deficit of $7,570,000 and a stockholders’ deficiency of $3,153,000. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The Company intends to continue to finance its operating activities by raising capital. There are no assurances that the Company will be successful in obtaining an adequate level of financing needed for its long-term research and development activities on commercially reasonable terms or at all. If the Company will not have sufficient liquidity resources, the Company may not be able to continue the development of its product candidates or may be required to implement cost reduction measures and may be required to delay part of its development programs.

The financial statements do not include any adjustments for the values of assets and liabilities and their classification that may be necessary in the event that the Company is no longer able to continue its operations as a “going concern”.

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

The interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The interim financial statements do not include a full disclosure as required in annual financial statements and should be read with the annual financial statements of the Company as of December 31, 2023 from which the accompanying condensed consolidated balance sheet dated December 31, 2023, was derived. The accounting policies implemented in the interim financial statements are consistent with the accounting policies implemented in the annual financial statements as of December 31, 2023, except of the following accounting pronouncement adopted by the Company.

Recently Issued Accounting Pronouncements

Effective January 1, 2024, the Company adopted ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), which is intended to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. For convertible instruments, ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stocks, and enhances information transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share guidance on the basis of feedback from financial statement users. The adoption of this new accounting guidance did not have an effect on the consolidated financial statements.

Effective January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326),” referred to herein as ASU 2016-13, which significantly changes how entities will account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaced the existing incurred loss model with an expected credit loss model that requires entities to estimate an expected lifetime credit loss on most financial assets and certain other instruments. Under ASU 2016-13 credit impairment is recognized as an allowance for credit losses, rather than as a direct write-down of the amortized cost basis of a financial asset. The impairment allowance is a valuation account deducted from the amortized cost basis of financial assets to present the net amount expected to be collected on the financial asset. Once the new pronouncement is adopted by the Company, the allowance for credit losses must be adjusted for management’s current estimate at each reporting date. The new guidance provides no threshold for recognition of impairment allowance. Therefore, entities must also measure expected credit losses on assets that have a low risk of loss. For instance, trade receivables that are either current or not yet due may not require an allowance reserve under current generally accepted accounting principles, but under the new standard, the Company will have to estimate an allowance for expected credit losses on trade receivables under ASU 2016-13. The Company determined the adoption of this new accounting guidance and the effect on its financial statements throughout the period until implementation, and have no impact on the financial statements.

In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s financial statements.

Use of Estimates in Preparation of Financial Statements

The preparation of consolidated financial statements in conformity with U.S. GAAP accounting principles requires management to make estimates and assumptions. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition

The Company recognizes revenue under ASC 606, Revenue Recognition at the amount to which it expects to be entitled when control of the products or services is transferred to its customers.

We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied.

Our contracts are typically governed by a customer purchase order. The contract generally specifies the delivery of what constitutes a single performance obligation. If an arrangement involves multiple performance obligations, the items are analyzed to determine the separate units of accounting, whether the items have value on a standalone basis and whether there is objective and reliable evidence of their standalone selling price. The total contract transaction price is allocated to the identified performance obligations based upon the relative standalone selling prices of the performance obligations. The standalone selling price is based on an observable price for services sold to other comparable customers.

As discussed in more detail below, revenue is recognized when a customer obtains control of promised goods or services under the terms of a contract and is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. We do not have any material extended payment terms, as payment is due at or shortly after the time of the sale. Sales, value-added and other taxes collected concurrently with revenue producing activities are excluded from revenue.

A contract liability is recognized as deferred revenue when we invoice customers, or receive customer cash payments, in advance of satisfying the related performance obligation(s) under the terms of a contract. Deferred revenue is recognized as revenue when we have satisfied the related performance obligation.

We have one main revenue stream: wristband sales, with the AppySleep App. For this revenue stream, our performance obligations are satisfied at a point in time, and therefore, revenue is recognized at point in time when a customer takes control of the good or asset created by the service. Factors that may indicate transfer of control are when we have the right to receive payment for the good or service, when the legal title of the asset has been transferred, physical possession of the asset has been transferred, the customer obtains the significant risks and rewards of ownership of the asset, and the customer accepts the asset. For customers, control is transferred upon delivery.

We leverage drop-ship shipments with our partners and suppliers to deliver wristbands to our customers without having to physically hold the inventory at our warehouses, thereby increasing efficiency and reducing costs. We recognize revenue for drop-ship arrangements on a gross basis as the principal in the transaction when the product is received by the customer because we control the product prior to transfer to the customer. We also assume primary responsibility for the fulfillment in the arrangement, we assume inventory risk if something were to happen to the hardware during shipping, we set the price of the product charged to the customer.

The Company intend to recognize records reductions to Products net sales related to future product returns, price protection and other customer incentive programs based on the Company’s expectations and historical experience.

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 3 - RELATED PARTY BALANCES AND TRANSACTIONS

Short-term loans from related parties

During 2021, SleepX borrowed from Nexense Technologies USA. Inc., a Delaware corporation which is majority owned by Boris Molchadsky, the Company’s Chairman. an aggregate amount of $47,623. According to the agreement, the loan shall be repaid in the event that the Company’s profits are sufficient to repay the aggregate loan amount and upon such terms and in such installments as shall be determined by the Board. The loan shall bear interest at an annual rate equal to the minimum rate approved by applicable law in Israel (5.18% in 2024).

During 2020, the minority shareholder of Ta-nooma advanced a loan to Ta-nooma in the amount of NIS 115,725. The loan does not carry any interest expense and the repayment terms have yet to be determined. As of March 31, 2024, the loan balance amounted to NIS 115,725 ($31,906).

Balances with related parties

	March 31, 2024		December 31, 2023
	In U.S. dollars in thousands

Liabilities:
Employees and payroll accruals		267		498
Related party payables		208		129
Short term loans		79		79

Transactions with related parties

	2024		2023
	For the three months ended March 31,
	2024		2023
	In U.S. dollars in thousands
Expenses:
Salaries and related cost (including stock-based compensation in the amount of $116,000 and $721,000, respectively)		190		1,067

Both the Chairman and the chief financial officer are directors in the Company and do not receive compensation for their directorship roles. Company’s Bylaws provide that a director or officer shall be indemnified and held harmless by the Corporation, to the fullest extent permitted by the laws of the State of Nevada.

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 4 - CONVERTIBLE LOANS AND WARRANTS

The following table summarizes fair value measurements by level as of March 31, 2024 and December 31, 2023 measured at fair value on a recurring basis:

SCHEDULE OF FAIR VALUE RECURRING BASIS

December 31, 2023	Level 1		Level 2		Level 3		Total
	In U.S. dollars
Assets
None		-		-		-		-

Liabilities
Convertible Loans At fair value		-		-		1,203		1,203
Financial liability				-		204		204

March 31, 2024	Level 1		Level 2		Level 3		Total
	In U.S. dollars
Assets
None		-		-		-		-

Liabilities
Convertible Loans At fair value		-		-		2,160		2,160
Financial liability				-		72		72

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 4

CONVERTIBLE LOANS AND WARRANTS (cont.)

The Convertible Loans changes consist of the following as of March 31, 2024 and December 31, 2023:

	March 31, 2024		December 31, 2023
	Convertible Loans at Fair Value
	March 31, 2024		December 31, 2023
	$000
Opening Balance, (including short term loans from related party which is also convertible)		1,203		2,257
Additional convertible loans (a)		-		153
Conversion of convertible loan (b)		-		(243	)
Decrease of notes purchased		-		(530	)
Change in fair value of convertible loans liability		957		(434	)
Closing balance		2,160		1,203

(a)

During the quarter ended March 31, 2024, and the year ended December 31, 2023, the Company raised a principal amount of nill and $152,750, respectively.

(b)

During the quarter ended March 31, 2024, and the year ended December 31, 2023 a total amount of nill and $242,538 (which were converted into 8,634,616 shares of common stock), respectively.

The estimated fair values of the Convertible loans were measured according to the Monte Carlo Model using the following assumptions:

	As of			As of
	March 31, 2024			December 31, 2023
Expected term (in years)		0.25			0.5
Expected average (Monte Carlo) volatility		83	%		213	%
Expected dividend yield		-			-
Risk-free interest rate		5.46	%		5.26	%
WACC		27	%		27	%

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 4

CONVERTIBLE LOANS AND WARRANTS (cont.)

The following table summarizes information relating to outstanding and exercisable warrants as of December 31, 2023:

Warrants Outstanding and Exercisable
Number of Warrants		Weighted Average Remaining Contractual life (in years)		Weighted Average Exercise Price		Valuation as of December 31, 2023
	8,334		2.16		0.6	$	23
	32,500		2.61		0.6	$	116
	7,000,000		0.46		0.015	$	203,718

The following table summarizes information relating to outstanding warrants as of March 31, 2024:

Warrants Outstanding
Number of Warrants		Weighted Average Remaining Contractual life (in years)		Weighted Average Exercise Price		Valuation as of March 31, 2024

	7,000,000		0.21		0.01024	$	71,702
	8,334		1.91		0.6	$	23
	32,500		2.36		0.6	$	116

The estimated fair values of the Warrants were measured according to the data as follows:

	As of			As of
	March 31, 2024			December 31, 2023
Expected term		0.21			0.46
Expected average volatility		87	%		224	%
Expected dividend yield		-			-
Risk-free interest rate		4.19	%		5.3	%
Common Stock Market Value	$	0.01024		$	0.015
Warrants rights outstanding measurement input	$	0.01024		$	0.015

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 4

CONVERTIBLE LOANS AND WARRANTS (cont.)

The Convertible Loans at amortized cost changes consist of the following as of March 31, 2024 and December 31, 2023:

	March 31, 2024		December 31, 2023
	$000
Opening balance		796		-
Transition from convertible loans measured at fair value to measurement at amortized cost		-		530
Beneficial conversion feature		-		(66	)
Financial expenses related to transition from fair value measurement to amortized cost		-		304
Accrued interest through profit or loss		15		28
Closing balance		811		796

NOTE 5 - STOCK BASED COMPENSATION

The table below depicts the number of options granted to employees and service providers:

SCHEDULE OF NUMBER OF OPTIONS

	Three months ended March 31, 2024
	Number of			Weighted average exercise price
	options			in USD

Options outstanding at January 1, 2024		62,349,647		$	0.0007
Options granted during the period		7,900,000		$	0.00373
Options exercised during the period*		(500,000	)	$	0.0001
Options outstanding at the end of period		69,749,647		$	0.00107
Options exercisable at the end of period		25,650,311		$	0.00136

*	A board member exercised his options into shares during the quarter

For the three months ended March 31, 2024 and 2023 the company recognized expenses, to such options, in the amount of $147,000 and $279,000, respectively. The expense is non-cash stock-based compensation expense resulting from options awards to the Chief Executive Officer, Chief Financial Officer and advisors The expense represents the aggregate grant date fair value for the option awards granted and vested during the fiscal years presented, determined in accordance with FASB ASC Topic 718.

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 6 - SIGNIFICANT EVENTS DURING THE PERIOD

On January 1, 2024, the Company engaged with a consultant. For his services he was granted stock option to purchase 2,300,000 of the Company’s Common Stock, valued at $34,350. The Options are vested on a monthly basis, over a period of 30 months as of the commencement date ending June 30, 2026. The options are exercisable at a per share exercise price of $0.01 and are otherwise subject to the other terms and conditions specified in an Option Grant Agreement to be entered into between optionee and the Company.

On January 1, 2024, the Company engaged with an additional consultant. For his services, he was granted a stock option to purchase 600,000 of the Company’s Common Stock, valued at $8,961. The Options are vested on a monthly basis, over a period of 30 months as of the Commencement Date ending June 30, 2026. The Option are exercisable at a per share exercise price of $0.01 and are otherwise subject to the other terms and conditions specified in an Option Grant Agreement to be entered into between optionee and the Company.

	C.	On January 1, 2024, the Company engaged with a note holder as a consultant. For his services, he was granted a stock option to purchase 5,000,000 of the Company’s Common Stock, valued at $74,675. Upon grant, the Options vest on a monthly basis, over a period of 12 months as of the Commencement Date ending December 31, 2024. The Option are exercisable at a per share exercise price of $0.0001.

	D.	During the first quarter of 2024, the company received an additional investment of $456,431 and registered shares to be issued from that investment in the amount of 7,500,000 common shares.

	E.	On August 11, 2022, a lawsuit was filed in the Tel Aviv Magistrate’s Court against our Chairman and majority shareholder, Boris Molchadsky, G.P.I.S Ltd., an entity controlled by Mr. Molchadsky, Nexsense, Inc. (the former shareholder of SleepX Ltd.) and SleepX, Ltd., our subsidiary (collectively, the “Defendants”) [Civil lawsuit number 25441-08-22]. The suit was filed by a fund operating out of Israel. A copy of the claim was served to the defendants only six months after it was submitted to court, on February 21, 2023. The lawsuit is based on the alleged breach of partnership and loan agreements as well as other related allegations, including violation of agreements reached in a mediation proceeding that took place in 2015. On July 24, 2023, the Defendants (except for Nexsense, Inc.) filed a statement of defense, denying the allegations and argued that the claim should be dismissed, due to the statute of limitations, lack of cause of action, lack of jurisdiction, delay in filing the claim, and respecting SleepX, also due to the lack of legal rivalry between SleepX and the plaintiff. Recently, the Magistrate’s Court in Tel Aviv accepted the request regarding lack of material jurisdiction, and the claim was then transferred to the economic department of the District Court in Tel Aviv. A preliminary hearing was held on February 14, 2024. The presiding judge did not rule on the preliminary pleadings and urged the parties to attempt mediation before the ruling. The parties are considering different mediators (which must be mutually agreed to) and following the selection of a mediator, the parties will schedule a date for the mediation. The Company cannot, at this stage, know the effects, if any, of these actions on its subsidiary SleepX and / or the Company, and accordingly, no provision was recorded.

NOTE 7 - SUBSEQUENT EVENTS

	A.	On May 13, 2024, Mr. Neil Kline announced the company on his resignation from the board of directors of the company. In Parallel, Mr. Kline signed an advisor agreement with the company to serve as an advisor of the Board, and provide services related to the development of company future products, creating marketing tools for company needs, and assist with filings and projects of the company.

	B.	On May 14, 2024, the Board of the Company (the “Boad”) approved the conversion of outstanding amounts owed to its officers and directors for unpaid compensation for options of the Company’s common stock, as follows: Boris Molchadsky, the Company chairman, and Asaf Porat, the Company CFO, agreed to convert a portion their unpaid compensation into options for shares of the Company’s common stock at a per share conversion rate of $0.07 and $0.04, respectively, and Adi Shemer, the Company CEO, has agreed to convert the entire unpaid compensation to him into options for shares of the Company’s common stock at per share conversation date of $0.04, in each case under a Company compensation Plan to be approved by the Company and its shareholders and qualified under Sections 102 and 103 of the Israeli tax authorities (such being the “Qualified Equity Interests”). There remains outstanding unpaid compensation to each of Mr. Molchadsky and Porat in the amount of $70,000 and $50,000, respectively. It was agreed that the unpaid compensation which was not converted would be paid in 20 equal monthly instalments, subject to payment of payroll, social security and other taxes, commencing on the 30^th day following the earlier to occur of (i) the closing of an equity raise by the Company with proceeds to the Company of at least $1.5 million, (ii) the completion of seven consecutive (7) months positive cash flow for the Company in such amount as will allow the Company to cover its operating expenses and (iii) termination of employment by the Company of for any reason other than cause. As of April 1, 2024 the Company converted the outstanding amounts related to its officers and directors and issued 6,959,692 options, which are exercisable with an exercise ratio of 1:1.

	C.	In addition, the Board approved the issuance of stock option to purchase 6,000,000 shares of the Company’s common stock, at a per share exercise price of $0.0001, to Adi Shemer, the Company CEO. Under his terms of his employment agreement, Mr. Shemer is entitled to these options following the issuance by the Company of at least 100 million shares of common stock in respect of third-party investments in the Company, which was satisfied in February 2024. The options will vest in full on July 1, 2024. For the three-month ended March 31, 2024 the Company recorded an expense related to the issuance of $49,492 out of a total expense of $197,966.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws, and is subject to the safe-harbor created by such Act and laws. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” the negative of such terms, or other variations thereon or comparable terminology. The statements herein and their implications are merely predictions and therefore inherently subject to known and unknown risks, uncertainties, assumptions and other factors that may cause actual results, performance levels of activity, or our achievements, or industry results to be materially different from those contemplated by the forward-looking statements. Except as required by law, we undertake no obligation to release publicly the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Further information on potential factors that could affect our business is described under the heading “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission, or the SEC, on April 1, 2024 As used in this quarterly report, the terms “we”, “us”, “our”, the “Company” and “AppYea” mean AppYea, Inc. and our wholly-owned subsidiaries Sleepx LTD and Ta-Nooma LTD unless otherwise indicated or as otherwise required by the context.

Overview

AppYea, Inc. is a digital health company, focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring and fundamentally improve quality of life.

Our solutions are based on our proprietary intellectual property portfolio comprised of Artificial Intelligence (AI) and sensing technologies for the tracking, analysis, and diagnosis of vital signs and other physical parameters during sleep time, offering extreme accuracy at affordable cost.

AI is a broad term generally used to describe conditions where a machine mimics “cognitive” functions associated with human intelligence, such as “learning” and “problem solving. Basic AI includes machine learning, where a machine uses algorithms to parse data, learn from it, and then make a determination or prediction about a given phenomenon. The machine is “trained” using large amounts of data and algorithms that provide it with the ability to learn how to perform the task.

General Background

Snoring is a general disorder caused due to repetitive collapsing and narrowing of the upper airway. Individuals with snoring problems are at increased risk of accidental injury, depression and anxiety, heart disease and stroke. Currently available treatments include surgical and non-surgical devices.

According to Fior Markets, a market intelligence company, the Global Anti-Snoring Treatment Market is expected to grow from USD 4.3 billion in 2020 to USD 8.6 billion by 2028, with a 9.07% CAGR between 2021 and 2028. While North America had the largest market share of 28.12% in 2020, Asia-Pacific region is witnessing significant growth due to the increasing prevalence of obesity and sedentary lifestyles in emerging economies.

Currently available anti-snoring devices consist mainly of oral appliances that are recommended for use by patients suffering from snoring or obstructive sleep apnea. These appliances are put before sleep and have a simple function of pushing either the lower jaw or the tongue forward. This keeps the epiglottis parted from the uvula and prevents the snoring sound created by the vibration of soft tissues of palate.

Sleep apnea is a severe sleep condition in which individuals frequently stop breathing in their sleeping, this leads to insufficient oxygen supply to the brain and the rest of the body which, in turn may lead to critical problems. There are three main types of apneas: (i) Obstructive Sleep Apnea (“OSA”), the most common form caused by the throat muscles relaxing during sleep; (ii) Central sleep apnea, which occurs when the brain doesn’t send the proper signals to the muscles that control the breathing; and (iii) complex sleep apnea syndrome, which occurs when an individual suffers from both OSA and central sleep apnea. While OSA is a common disorder in the elderly population, affecting approximately 13 to 32% of people aged over 65, sleep apnea can occur at any age and affects approximately 25% of men and nearly 10% of women.

In 2020, North America dominated the sleep apnea device market, as it accounted for 49% of the revenue, the global market size was valued at USD 3.7 billion and is expected to expand by 6.2% CAGR, according to a report by Grand View Research Inc., reaching USD 6.1 billion by 2028.

The global sleep apnea and snoring market is driven in large part by solutions that can be applied in at home-settings or healthcare settings, as these tools will drive decisions regarding specific treatments and the associated outlays. However, despite advances in medical imaging and other diagnostic tools, misdiagnosis remains a common occurrence. We believe that improved diagnoses and outcomes are achievable through the adoption of AI-based decision support tools.

Our Products and Product Candidates

Our initial focus is on the development of supporting solutions utilizing our proprietary platform. Our current business plan focuses on two principal devices and an App currently in development:

AppySleep – Biofeedback snoring treatment wristband, combined with the AppySleep App.

The AppySleep app uses unique algorithms developed by SleepX combined with sensors to monitor physiological parameters during sleep. Based on real time reactions, the wristband will vibrate, when necessary, in order to decrease the snoring and regulate breathing by gently bringing the user to a lighter sleep or change his sleep position and thus ceasing the snoring event.

The AppySleep product is currently in serial manufacturing stage and sales.

AppySleep LAB – Is a medical application, intended for downloading on a smartphone, and used to monitor breathing patterns in the sleep and identify sleep apnea episodes without direct contact to the user.

The AppySleep LAB product is to begin final calibration, following which we will file for 510(k) FDA approval.

AppySleep PRO – is a wristband for the treatment of sleep apnea using biofeedback in combination with AppySleep LAB app. The unique algorithms of AppySleep LAB, combined with the wristband sensors, monitor sleep apnea events and additional physiological parameters during sleep, and when necessary, the wristband vibrates according to real time events, in order to decrease and cease sleep apnea events.

The AppySleep PRO and AppySleep LAB are currently in development stages, following which it would be ready to begin the testing stage in preparation for filing for FDA approval.

Our Strategy

We started marketing of the AppySleep app and wristband in the first quarter of 2024. Concurrently, we plan to file a 510(k) FDA submission for the AppySleep LAB app for the non-contact diagnosis of sleep apnea during 2024, and an FDA process for AppySleep PRO for the treatment of sleep apnea during 2026.

Our goal over the next five years is to establish our technology and related products as the gold standard for the targeted sectors. The key elements of our strategy are as follows:

Develop and expand a balanced and diverse pipeline of products and product candidates. Our core platform technologies will include innovative anti-snoring and sleep apnea related devices and product candidates in various development and clinical stages. We plan to add products and product candidates to our pipeline by expanding our technologies being developed to additional indications and through investing in new technologies, products and product candidates. By maintaining this multi-product approach, we aim to provide a broad and comprehensive product offering, which we believe will result in multiple value inflection events, reduced risks to our potentially business associated with a particular product or product candidate and increased return on investment. Furthermore, product candidates that we develop may create attractive collaboration opportunities with diagnostics, medical devices and medical supplies companies.

Maintain a global, diverse network of specialists to accelerate knowledge synergies and innovation. We will utilize a global network of specialists to identify large and growing patient populations with significant unmet needs, evaluate and prioritize potential technologies, assist in designing development plans and diagnostic protocols and determine potential indications of our platform technologies to our target patient populations in various territories. We believe that maintaining this diverse network of specialists and industry specialists will allow us to continue to maximize knowledge and cost synergies, utilize shared commercial infrastructure across products, reduce risks of development and commercialization delays to our overall business and leverage our current and future platform technologies and technologies for additional products and product candidates.

Establish distribution channels to maximize the commercial potential of our products. We plan to seek out collaborative arrangements with major healthcare providers and consumer specialists to facilitate market adoption of our product candidates. We believe that such institutions are well positioned to directly benefit from improvements in accurate diagnosis and reduction of cost of care associated with the use of our product candidates. We also believe that the marginal cost of our product candidates compared to potential savings will make it economical for healthcare institutions to adopt our products regardless of whether or not additional costs of purchase of these products will be covered by third-party payors, such as government health care programs and commercial insurance companies. Through cooperation with healthcare providers, we aim to develop and prove an economic model beneficial to them. In parallel, we intend selling directly, through our website and other online webstores worldwide. Thereafter, we plan to engage with private insurance plans to develop reimbursement programs encouraging the use of our product candidates. We expect that adoption rates of our product candidates will increase if hospitals and other medical institutions are compensated, in full or in part, for additional costs incurred when purchasing our products.

We established a logistical distribution facility in the US.

The License Agreement

Our business derives from a licensing agreement entered into as of March 15, 2020, as subsequently amended (the “License Agreement”), by SleepX Ltd., our Israeli subsidiary, B.G. Negev Technologies and Applications Ltd., a company formed under the laws of the State of Israel (“BGN”) and Mor Research Application Ltd. a company formed under the laws of Israel (“Mor”; together with BGN, the Licensors”). BGN is a company wholly owned by Ben Gurion University of the Negev in Israel and Mor, is the technology transfer arm of the Clalit Health Services, an Israeli non-profit healthcare insurance and service provider. Under the License Agreement, our Israeli subsidiary was granted a worldwide royalty bearing and exclusive license exclusive worldwide license with the right to grant sub-licenses and with a term of 15 years, to certain intellectual property to research, develop, manufacture use, market, distribute, offer for sale and sell sensor and software solutions for monitoring snoring and sleep apnea.

On May 1, 2022, our Israeli subsidiary and the Licensors entered into an amendment to the License Agreement (the “Amended License Agreement”) to include under the license certain sleep apnea treatment solutions that by combining speech descriptors from three separate and distinct speech signal domains, these speech descriptors may provide the ability to estimate the severity of sleep apnea using statistical learning and speech analysis approaches.

As consideration for the licenses above, our Israeli subsidiary has agreed to pay the following to the Licensors:

(i)

A royalty of 3.0% of net sales received from the licensed products for a period of up to 15 years from initiation of sales in each state using licensed intellectual property;

	(ii)	25% of sublicense fees received prior to attainment of all regulatory approval for marketing and sale of the licensed products in the first jurisdiction where the licensed products are intended to be sold; thereafter, 15% of sublicense fees received after the date regulatory approval, but prior to the first commercial sale of the licensed products; and 10% of sublicense fees received after the first commercial sale;

	(iii)	An annual license fee, commencing on fifth anniversary of the License Agreement (i.e., March 2025) of $20,000, and thereafter on each anniversary date as follows

Year	Amount ($)
6	$	40,000
7	$	60,000
8	$	80,000
9-15	$	100,000

The Annual Fee is non-refundable, but it shall be credited each year due, against the royalty noted above, to the extent that such are payable, during that year.

(iv)

Milestone payment of $60,000 upon the attainment of regulatory approval from applicable authority in USA or Europe to market and sell the licensed products

As of the date of these financials, we have not achieved any of these milestones.

Under the License Agreement, the Licensors are entitled to terminate the License Agreement under certain conditions relating to a material change in the business of our Israeli subsidiary or a breach of any material obligation thereunder or to a bankruptcy event of our Israeli subsidiary. Under certain conditions, our Israeli subsidiary may terminate the License Agreement and return the licensed information to the Licensors.

In the event of an acquisition of all of the issued and outstanding share capital of the Israeli Subsidiary or of the Company and/or consolidation of the Israeli Subsidiary or the Company into or with another corporation (“Non IPO Exit”) or a listing of our common stock on a national exchange such as Nasdaq (the IPO Exit”), then the Licensors shall be entitled to an exit fee equal to 5% of the valuation of our company at the time of such exit and with respect to an IPO Exit, shares of common stock which will reflect in the aggregate 5% of the then outstanding common stock of the Company.

Key Financial Terms and Metrics

The following discussion summarizes the key factors our management believes are necessary for an understanding of our consolidated financial statements.

Revenues

We have generated $13,000 in revenues from product sales as of 03.31.2024.

Research and Development Expenses

The process of researching and developing our product candidates is lengthy, unpredictable, and subject to many risks. We expect to continue incurring substantial expenses for the next several years as we continue to develop our product candidates. We are unable, with any certainty, to estimate either the costs or the timelines in which those expenses will be incurred. The design and development of our devices will consume a large proportion of our current, as well as projected, resources.

Our research and development costs include costs are comprised of:

● internal recurring costs, such as personnel-related costs (salaries, employee benefits, equity compensation and other costs), materials and supplies, facilities and maintenance costs attributable to research and development functions; and

● fees paid to external parties who provide us with contract services, such as programing, preclinical testing, manufacturing and related testing and clinical trial activities.

General and Administrative Expenses

General and administrative expenses consist primarily of salaries, employee benefits, equity compensation, and other personnel-related costs associated with executive, administrative and other support staff. Other significant general and administrative expenses include the costs associated with professional fees for accounting, auditing, insurance costs, consulting and legal services, along with facility and maintenance costs attributable to general and administrative functions.

Financial Expenses

Financial expenses consist primarily impact of exchange rate derived from re-measurement of monetary balance sheet items denominated in non-dollar currencies. Other financial expenses include bank’s fees and interest on long term loans. Financial income derives mainly from change in derivative value of convertible loans.

Results of Operations

Comparison of the Three Months Ended March 31, 2024 to the Three Months Ended March 31, 2023

	For the three- months period ended March 31
	2024			2023

Research and development expenses		60,000			9,000
General and administrative expenses		294,000			427,000

Financial income (expenses), net		(22,000	)		(19,000	)

Loss for the period		(1,244,000	)		(289,000	)

Revenues. We recorded revenues of $13,000 for the quarter ended March 31, 2024 from sales of our AppySleep wristband.

No revenues were recorded during the quarter ended March 31, 2023.

Research and Development Expenses, Research and development expenses increased from $9,000 during the three months ended March 31, 2023 to $60,000 for the quarter ended March 31, 2024. The increase in research and development expenses is primarily attributable to increased investment in intellectual property and development of our products during the first quarter of 2024.

Sales and Marketing. We recorded sales and marketing expenses of $54,000 for the quarter ended March 31, 2024 for sales of our AppySleep wristband through Amazon and our website.

No sales and marketing expenses were recorded during the quarter ended March 31, 2023.

General and Administrative Expenses. General and administrative expenses decreased from $427,000 for the three months ended March 31, 2023 to $294,000 for the for the quarter ended March 31, 2024. The decrease is primarily due to salary and professional services expenses, of which $147,281 were non-cash stock based non-cash compensation expenses resulting from options awards to our management and advisors.

Loss. Loss for the three months ended March 31, 2024 was $1,244,000 and is primarily attributable to change in fair value of convertible loans caused mainly by the rise in the stock price.

Liquidity and Capital Resources

From inception, we have funded our operations from a combination of loans and sales of equity.

As of March 31, 2024, we had a total of $373,000 in cash resources and approximately $3,825,000 of liabilities, all of which are current liabilities.

AppYea has experienced operating losses since its inception and had a total accumulated deficit of $7,570,000 as of March 31, 2024. We expect to incur additional costs and require additional capital. We have incurred losses in nearly every year since inception. These losses have resulted in significant cash used in operations. During the fiscal quarters ended March 31, 2024 and 2023, our cash used in operations was approximately $257,000 and $97,000, respectively. We need to continue and amplify our research and development efforts for our product candidates (which are in various stages of development), strengthen our patent portfolio, establish operations processes and pursue FDA clearance and international regulatory approvals as we continue to conduct these activities, we expect the cash needed to fund operations to increase significantly over the next several years.

The following table provides a summary of operating, investing, and financing cash flows for the period ended March 31, 2024 and 2023 respectively:

	For the three months ended
	March 31, 2024		March 31, 2023
	US Dollars
Net cash used in operating activities	$	257,000		97,000
Net cash used in investment activities	$	50,000		0
Net cash provided by Financing Activities	$	456,000		141,000

Between June 2023 and March 2024, we raised an aggregate of $955,330 from private placement of shares of our common stock at a per share price of $0.01 and the issuance of warrants, exercisable for a two year period from the date of issuance for an identical number of shares at a per share exercise price of $0.04, and additional $225,000 from public capital raised through the company effective prospectus. In respect of the raise the investors are entitled to an aggregate 118,032,953 shares of our common stock and identical number of warrants, of which 86,776,100 have already been issued. The subscription proceeds are being used to complete the IOS design and development of our biofeedback snoring treatment wristband (AppySleep product) as well as general corporate matters.

Management believes that funds on hand, will enable us to fund our operations and capital expenditure requirements through the end of the third quarter of 2024. We need to raise additional operating capital in order to maintain operations as presently conducted and to realize our business plan.

Our accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these consolidated financial statements. However, the Company has incurred substantial losses. Our current liabilities exceed our current assets and available cash is not sufficient to fund the expected future operations. The Company is raising additional capital through debt and equity securities in order to continue the funding of its operations. However, there is no assurance that the Company can raise enough funds or generate sufficient revenues to pay its obligations as they become due, which raises substantial doubt about our ability to continue as a going concern. No adjustments have been made to the carrying value of assets or liabilities as a result of this uncertainty.

We cannot be sure that future funding will be available to us on acceptable terms, or at all. Due to often volatile nature of the financial markets, equity and debt financing may be difficult to obtain.

We may seek to raise any necessary additional capital through a combination of private or public equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements. To the extent that we raise additional capital through marketing and distribution arrangements or other collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights, future revenue streams, or product candidates or to grant licenses on terms that may not be favorable to us. If we raise additional capital through private or public equity offerings, the ownership interest of our existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our stockholders’ rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.

Going Concern

Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation. We have a stockholders’ deficit of $3,153,000 and a working capital deficit of $3,407,000 on March 31 2024, as well as negative operating cash flows. Our report from our independent registered public accounting firm for the Quarter ended March 31, 2024, includes an explanatory paragraph stating the Company has recurring losses and limited operations which raise substantial doubt about its ability to continue as a going concern. If the Company is unable to obtain adequate capital, the Company may be required to reduce the scope, delay, or eliminate some or all of its planned operations. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not Applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed by us in reports that we file under the Exchange Act is recorded, processed, summarized and reported as specified in the SEC’s rules and forms and that such information required to be disclosed by us in reports that we file under the Exchange Act is accumulated and communicated to our management, including our Interim Chief Executive Officer, to allow timely decisions regarding required disclosure. Management, with the participation of our Interim Chief Executive Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of March 31, 2024. Based on that evaluation, our management, including our Chief Executive Officer, concluded that our disclosure controls and procedures were not effective as of March 31, 2024.

Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. As disclosed in Item 9A of our Annual Report on Form 10-K/A for the year ended December 31, 2023 filed with the Securities and Exchange Commission on May 17, 2024, our management concluded that our internal control over financial reporting was not effective at December 31, 2023. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

As a result of our evaluation, we identified a material weakness in our controls related to segregation of duties and other immaterial weaknesses in several areas of data management and documentation. Our management is composed of a small number of professionals resulting in a situation where limitations on segregation of duties exist. Accordingly, and as a result of the material weakness identified above, we have concluded that the control deficiencies result in a reasonable possibility that a material misstatement of the annual or interim financial statements may not be prevented on a timely basis by the Company’s internal controls. We continue to employ and refine a structure in which critical accounting policies, issues and estimates are identified, and together with other complex areas, are subject to multiple reviews by executives. We expect to be materially dependent upon third parties to provide us with accounting consulting services for the foreseeable future which we believe will mitigate the impact of the material weaknesses discussed above.

Changes in Internal Control Over Financial Reporting

Except for the material weakness noted above, during the quarter ended March 31, 2024, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

In August 11, 2022, a lawsuit was filed in the Tel Aviv Magistrate’s Court against our Chairman and majority shareholder, Boris Molchadsky, G.P.I.S Ltd., an entity controlled by Mr. Molchadsky, Nexsense, Inc. (the former shareholder of SleepX Ltd.) and SleepX, Ltd., our subsidiary (collectively, the “Defendants”) [Civil lawsuit number 25441-08-22]. The suit was filed by a fund operating out of Israel. A copy of the claim was served to the defendants only six months after it was submitted to court, on February 21, 2023.

The lawsuit is based on the alleged breach of partnership and loan agreements as well as other related allegations, including violation of agreements reached in a mediation proceeding that took place in 2015.

The suit alleges that the Defendants, amongst other things, did not disclose to the plaintiff certain transactions to which the Plaintiff was presumably entitled to compensation and hence the plaintiff demanded an accounting of the transactions and refund of amounts invested. With respect to SleepX. the plaintiff alleged that it made a deal with Nexsense, Inc. which wasn’t disclosed to the plaintiff, while allegedly the technology and patents of Nexsense, Inc. were transferred to SleepX (which was established shortly before the reverse merger between AppYea and SleepX), thus allegedly aimed to the concealment of assets from the plaintiff.

On July 24, 2023, the Defendants (except for Nexsense, Inc.) filed a statement of defense, denying the allegations and argued that the claim should be dismissed, due to the statute of limitations, lack of cause of action, lack of jurisdiction, delay in filing the claim, and respecting SleepX, also due to the lack of legal rivalry between SleepX and the plaintiff.

In addition, the Defendants submitted several preliminary requests to dismiss the claim outright, including a plea to dismiss the claim on the grounds it was submitted to the magistrate court, which is not the competent court according to law, due to the economic nature of the claim. Nexsense, Inc. submitted a request to dismiss the claim against it because it was not properly served under the law (given the different service rules for defendants whose domicile is outside of Israel).

Recently, the Magistrate’s Court in Tel Aviv accepted the request regarding lack of material jurisdiction, and the claim was then transferred to the economic department of the District Court in Tel Aviv.

A preliminary hearing was held on February 14, 2024. The presiding judge did not rule on the preliminary pleadings and urged the parties to attempt mediation before the ruling. The parties are considering different mediators (which must be mutually agreed to) and following the selection of a mediator, the parties will schedule a date for the mediation.

We cannot, at this stage, know the effects, if any, of these actions on our subsidiary SleepX and / or the Company. However, SleepX together with the other Defendants, intend to vigorously defend against the lawsuit.

Aside from the disclosure above, from time to time we may become involved in various legal proceedings that arise in the ordinary course of business, including actions related to our intellectual property. Although the outcomes of these legal proceedings cannot be predicted with certainty, we are currently not aware of any such legal proceedings that arise in the ordinary course of business, including actions related to our intellectual property. Although the outcomes of these legal proceedings cannot be predicted with certainty, we are currently not aware of any such legal proceedings or claims that we believe, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or results of operations.

From time to time we may become involved in various legal proceedings that arise in the ordinary course of business, including actions related to our intellectual property. Although the outcomes of these legal proceedings cannot be predicted with certainty, we are currently not aware of any such legal proceedings that arise in the ordinary course of business, including actions related to our intellectual property. Although the outcomes of these legal proceedings cannot be predicted with certainty, we are currently not aware of any such legal proceedings or claims that we believe, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or results of operations.

ITEM 1A. RISK FACTORS

An investment in the Company’s Common Stock involves a number of very significant risks. You should carefully consider the risk factors included in the “Risk Factors” section of our annual report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 1, 2024, as amended on May 17, 2024 in addition to other information contained in our reports and in this quarterly report in evaluating the Company and its business before purchasing shares of our Common Stock. There have been no material changes to our risk factors contained in such registration statement.

ITEM 2. UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS

During the covered by this report period, we committed to issue to four investors an aggregate of 45,643,100 shares of our common stock upon investment of $456,431. As of the date of this report, 30,643,100 shares of common stocks have been issued with respect to this investment.

We relied upon the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Act”) by virtue of Section 4(a)(2) thereof and/or Regulation S promulgated by the SEC under the Act with respect to the issuance of such securities.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION:

During the fiscal quarter ended March 31, 2024, none of our directors or executive officers adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

ITEM 6. EXHIBITS

Exhibit Index:

10.1*		Debt Conversion and Settlement Agreement between Bary Molchadsky and Appyea Inc.

10.2*		Debt Conversion a Agreement between Adi Shemer and Appyea Inc.

10.3*		Debt Conversion and Settlement Agreement between Asaf and Appyea Inc.

31.1		Certification of Chief Executive Officer (Principal Executive Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

31.2		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

32.1		Certification of Chief Executive Officer (Principal Executive Officer), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

101.INS		Inline XBRL Instance Document

101.SCH		Inline XBRL Taxonomy Extension Schema

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Incorporated by reference from the Current Report on Form 8-K filed on May 17, 2024

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

AppYea, Inc.

(Registrant)

By:	/s/ Adi Shemer	By:	/s/ Asaf Porat
	Adi Shemer		Asaf Porat
	Chief Executive Officer		Chief Financial Officer
	(Principal Executive Officer)		(Principal Financial and Accounting Officer)

Date: May 20, 2024		Date: May 20, 2024

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

OF REGISTRANT PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(RULE 13a-14(a) or 15d-14(a) OF THE EXCHANGE ACT)

I, Adi Shemer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of AppYea, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ Adi Shemer
	Adi Shemer, Chief Executive Officer
	(Principal Executive Officer)

Date: May 20, 2024

EX-31.2 3 ex31-2.htm

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

OF REGISTRANT PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(RULE 13a-14(a) or 15d-14(a) OF THE EXCHANGE ACT)

I, Asaf Porat, certify that:

1. I have reviewed this quarterly report on Form 10-Q of AppYea, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ Asaf Porat
	Asaf Porat, Chief Financial Officer
	(Principal Financial and Accounting Officer)

Date: May 20, 2024

EX-32.1 4 ex32-1.htm

EXHIBIT 32.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned Principal Executive Officer of AppYea, Inc. (the “Company”) hereby certifies to such officer’s knowledge that:

(i) the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Adi Shemer
Adi Shemer, Chief Executive Officer
(Principal Executive Officer)

Dated: May 20, 2024

EX-32.2 5 ex32-2.htm

EXHIBIT 32.2

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Asaf Porat
Asaf Porat, Chief Financial Officer
(Principal Financial and Accounting Officer)

Dated: May 20, 2024

EX-101.SCH 6 apyp-20240331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Deficiency (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - GENERAL link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - CONVERTIBLE LOANS AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - STOCK BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - SIGNIFICANT EVENTS DURING THE PERIOD link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - CONVERTIBLE LOANS AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - STOCK BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - GENERAL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - SCHEDULE OF FAIR VALUE RECURRING BASIS (Details) link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED (Details) link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST (Details) link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - SCHEDULE OF NUMBER OF OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - STOCK BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - SIGNIFICANT EVENTS DURING THE PERIOD (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 apyp-20240331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 apyp-20240331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 apyp-20240331_lab.xml XBRL LABEL FILE Related and Nonrelated Parties [Axis] Related Party [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Stock Payables [Member] Retained Earnings [Member] Parent [Member] Noncontrolling Interest [Member] Nexense Technologies LTD [Member] Related Party Transaction [Axis] Legal Entity [Axis] Tanooma Ltd [Member] Class of Warrant or Right [Axis] Old CLA [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Measurement Input Type [Axis] Measurement Input, Price Volatility [Member] Measurement Input, Expected Dividend Rate [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input Common Market Value [Member] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Title and Position [Axis] Consultants and Employees [Member] Chief Financial Officer And Advisor [Member] Consultant [Member] Consultant One [Member] Consultant Two [Member] Boris Molchadsky [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Asaf Porat [Member] Adi Shemer [Member] Officer And Director [Member] Statistical Measurement [Axis] Minimum [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current assets Cash and cash equivalents Accounts receivables Other accounts receivables Inventory Total current assets Non-current assets Property and equipment, net Intangible assets, net Total non-current asset Total assets LIABILITIES AND DEFICIENCY Current liabilities Trade payables Other accounts payable Short-term loans from related party Convertible loans at amortized cost Convertible loans – At fair value Financial liability at fair value Total current liabilities Total liabilities DEFICIENCY AppYea Inc. Stockholders’ Deficiency: Convertible preferred stock, $0.0001 par value Common stock, $0.0001 par value Stock payables Additional Paid in Capital Accumulated deficit Total AppYea Inc. stockholders’ deficiency Non-controlling interests Total Deficiency Total liabilities and deficiency Statement of Financial Position [Abstract] Convertible preferred stock, par value Common stock, par value Income Statement [Abstract] Sales Cost of sales Gross profit Research and development expenses Sales and marketing General and administrative expenses Operating loss Change in fair value of convertible loans and warrant liability Financial income (expenses), net Loss before income tax benefit Income tax benefit Net loss Net loss attributable to AppYea Inc. Net Loss per Common Share: Net Loss Per Common Share: Basic Net Loss Per Common Share: Diluted Weighted Average number of Common Shares Outstanding basic Weighted Average number of Common Shares Outstanding diluted Statement [Table] Statement [Line Items] Balance Balance, shares Share based Compensation Net loss Shares to be issued Shares to be issued to service providers Issuance of Shares Issuance of Shares, shares Shares to be issued to investors Options exercise Options exercise, shares Share issuance upon conversion of Convertible notes. Share issuance upon conversion of Convertible notes, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile loss to net cash used in operating activities: Depreciation and amortization Share based compensation Change in fair value of convertible loans and warrant liability Financial expenses, net Changes in operating assets and liabilities: Other current assets Accounts payables Accounts payables – related party Net cash used in operating activities Cash flows from investing activities: Research and development expenses capitalization Net cash used in investing activities Cash flows from financing activities: EX-101.PRE 10 apyp-20240331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 20, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	000-55403
Entity Registrant Name	APPYEA, Inc.
Entity Central Index Key	0001568969
Entity Tax Identification Number	46-1496846
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	16 Natan Alterman St
Entity Address, City or Town	Gan Yavne
Entity Address, Country	IL
City Area Code	(800)
Local Phone Number	674-3561
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		451,113,064

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 373	$ 222
Accounts receivables	1
Other accounts receivables	30	42
Inventory	14	14
Total current assets	418	278
Non-current assets
Property and equipment, net	2	3
Intangible assets, net	238	193
Total non-current asset	240	196
Total assets	658	474
Current liabilities
Trade payables	24	51
Other accounts payable	679	694
Convertible loans at amortized cost	811	796
Convertible loans – At fair value	2,160	1,203
Financial liability at fair value	72	204
Total current liabilities	3,825	3,027
Total liabilities	3,825	3,027
AppYea Inc. Stockholders’ Deficiency:
Convertible preferred stock, $0.0001 par value
Common stock, $0.0001 par value	41	31
Stock payables	657	559
Additional Paid in Capital	3,719	3,197
Accumulated deficit	(7,570)	(6,326)
Total AppYea Inc. stockholders’ deficiency	(3,153)	(2,539)
Non-controlling interests	(14)	(14)
Total Deficiency	(3,167)	(2,553)
Total liabilities and deficiency	658	474
Related Party [Member]
Current liabilities
Short-term loans from related party	$ 79	$ 79

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Convertible preferred stock, par value	$ 0.0001	$ 0.0001
Common stock, par value	$ 0.0001	$ 0.0001

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Sales	$ 13
Cost of sales	(3)
Gross profit	10
Research and development expenses	(60)	(9)
Sales and marketing	(54)
General and administrative expenses	(294)	(427)
Operating loss	(398)	(436)
Change in fair value of convertible loans and warrant liability	(824)	166
Financial income (expenses), net	(22)	(19)
Loss before income tax benefit	(1,244)	(289)
Income tax benefit
Net loss	(1,244)	(289)
Net loss attributable to AppYea Inc.	$ (1,244)	$ (289)
Net Loss per Common Share:
Net Loss Per Common Share: Basic	$ (0.003)	$ (0.001)
Net Loss Per Common Share: Diluted	$ (0.003)	$ (0.001)
Weighted Average number of Common Shares Outstanding basic	380,266,957	225,248,108
Weighted Average number of Common Shares Outstanding diluted	380,266,957	225,248,108

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Changes in Deficiency (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Balance	$ (2,553)	$ (2,563)
Share based Compensation	147	279
Net loss	(1,244)	(289)
Shares to be issued		1
Shares to be issued to service providers	25
Issuance of Shares	383
Shares to be issued to investors	75
Options exercise
Share issuance upon conversion of Convertible notes.		161
Balance	(3,167)	$ (2,411)
Preferred Stock [Member]
Balance
Balance, shares	258,745	300,000
Share based Compensation
Net loss
Shares to be issued
Share issuance upon conversion of Convertible notes.
Share issuance upon conversion of Convertible notes, shares	(28,147)
Balance
Balance, shares	230,598	300,000
Common Stock [Member]
Balance	$ 31	$ 21
Balance, shares	328,836,657	220,930,798
Share based Compensation
Net loss
Shares to be issued
Shares to be issued to service providers
Issuance of Shares	$ 6
Issuance of Shares, shares	60,143,100
Shares to be issued to investors
Options exercise
Options exercise, shares	500,000
Share issuance upon conversion of Convertible notes.	$ 4	$ 1
Share issuance upon conversion of Convertible notes, shares	42,217,500	8,634,616
Balance	$ 41	$ 22
Balance, shares	431,697,257	229,565,414
Additional Paid-in Capital [Member]
Balance	$ 3,197	$ 1,912
Share based Compensation	147	279
Net loss
Shares to be issued
Shares to be issued to service providers
Issuance of Shares	379
Shares to be issued to investors
Options exercise
Share issuance upon conversion of Convertible notes.	(4)	160
Balance	3,719	2,351
Stock Payables [Member]
Balance	559	27
Share based Compensation
Net loss
Shares to be issued		1
Shares to be issued to service providers	25
Issuance of Shares	(2)
Shares to be issued to investors	75
Options exercise
Share issuance upon conversion of Convertible notes.
Balance	657	28
Retained Earnings [Member]
Balance	(6,326)	(4,509)
Share based Compensation
Net loss	(1,244)	(289)
Shares to be issued
Shares to be issued to service providers
Issuance of Shares
Shares to be issued to investors
Options exercise
Share issuance upon conversion of Convertible notes.
Balance	(7,570)	(4,798)
Parent [Member]
Balance	(2,539)	(2,549)
Share based Compensation	147	279
Net loss	(1,244)	(289)
Shares to be issued		1
Shares to be issued to service providers	25
Issuance of Shares	383
Shares to be issued to investors	75
Options exercise
Share issuance upon conversion of Convertible notes.		161
Balance	(3,153)	(2,397)
Noncontrolling Interest [Member]
Balance	(14)	(14)
Share based Compensation
Net loss
Shares to be issued
Shares to be issued to service providers
Issuance of Shares
Shares to be issued to investors
Options exercise
Share issuance upon conversion of Convertible notes.
Balance	$ (14)	$ (14)

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (1,244)	$ (289)
Adjustments to reconcile loss to net cash used in operating activities:
Depreciation and amortization	6	6
Share based compensation	172	279
Change in fair value of convertible loans and warrant liability	824	(147)
Financial expenses, net	14
Changes in operating assets and liabilities:
Other current assets	11	1
Accounts payables	(24)	74
Accounts payables – related party	(16)	(21)
Net cash used in operating activities	(257)	(97)
Cash flows from investing activities:
Research and development expenses capitalization	(50)
Net cash used in investing activities	(50)
Cash flows from financing activities:
Proceeds from issuance of Common Stock	381
Proceeds from convertible Note received, net of issuance expenses		141
Proceeds on account of Shares to be issued	75
Net cash provided by financing activities	456	141
Foreign exchange on Cash and cash equivalents	3	(4)
Change in cash and cash equivalents	152	40
Cash and cash equivalents at beginning of period	222	60
Cash and cash equivalents at end of period	$ 373	$ 100

XML 18 R7.htm IDEA: XBRL DOCUMENT

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (1,244)	$ (289)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

XML 19 R8.htm IDEA: XBRL DOCUMENT

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML 20 R9.htm IDEA: XBRL DOCUMENT

GENERAL

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GENERAL

NOTE 1 - GENERAL

The Company’s common stock is traded on the OTC Markets, OTCQB tier, under the symbol “APYP”.

Strategic Development

The company flagship product is AppySleep – A Biofeedback snoring treatment wristband, combined with the AppySleep App (“AppySleep”).

The AppySleep product is currently in serial manufacturing and commercial stage.

Financial position

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

XML 21 R10.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

Recently Issued Accounting Pronouncements

Use of Estimates in Preparation of Financial Statements

Revenue Recognition

The Company recognizes revenue under ASC 606, Revenue Recognition at the amount to which it expects to be entitled when control of the products or services is transferred to its customers.

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

XML 22 R11.htm IDEA: XBRL DOCUMENT

RELATED PARTY BALANCES AND TRANSACTIONS

3 Months Ended

Mar. 31, 2024

RELATED PARTY BALANCES AND TRANSACTIONS

NOTE 3 - RELATED PARTY BALANCES AND TRANSACTIONS

Short-term loans from related parties

Balances with related parties

	March 31, 2024		December 31, 2023
	In U.S. dollars in thousands

Liabilities:
Employees and payroll accruals		267		498
Related party payables		208		129
Short term loans		79		79

Transactions with related parties

	2024		2023
	For the three months ended March 31,
	2024		2023
	In U.S. dollars in thousands
Expenses:
Salaries and related cost (including stock-based compensation in the amount of $116,000 and $721,000, respectively)		190		1,067

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

+ Details

XML 23 R12.htm IDEA: XBRL DOCUMENT

CONVERTIBLE LOANS AND WARRANTS

3 Months Ended

Mar. 31, 2024

Convertible Loans And Warrants

CONVERTIBLE LOANS AND WARRANTS

NOTE 4 - CONVERTIBLE LOANS AND WARRANTS

The following table summarizes fair value measurements by level as of March 31, 2024 and December 31, 2023 measured at fair value on a recurring basis:

SCHEDULE OF FAIR VALUE RECURRING BASIS

December 31, 2023	Level 1		Level 2		Level 3		Total
	In U.S. dollars
Assets
None		-		-		-		-

Liabilities
Convertible Loans At fair value		-		-		1,203		1,203
Financial liability				-		204		204

March 31, 2024	Level 1		Level 2		Level 3		Total
	In U.S. dollars
Assets
None		-		-		-		-

Liabilities
Convertible Loans At fair value		-		-		2,160		2,160
Financial liability				-		72		72

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 4

CONVERTIBLE LOANS AND WARRANTS (cont.)

The Convertible Loans changes consist of the following as of March 31, 2024 and December 31, 2023:

	March 31, 2024		December 31, 2023
	Convertible Loans at Fair Value
	March 31, 2024		December 31, 2023
	$000
Opening Balance, (including short term loans from related party which is also convertible)		1,203		2,257
Additional convertible loans (a)		-		153
Conversion of convertible loan (b)		-		(243	)
Decrease of notes purchased		-		(530	)
Change in fair value of convertible loans liability		957		(434	)
Closing balance		2,160		1,203

(a)

During the quarter ended March 31, 2024, and the year ended December 31, 2023, the Company raised a principal amount of nill and $152,750, respectively.

(b)

During the quarter ended March 31, 2024, and the year ended December 31, 2023 a total amount of nill and $242,538 (which were converted into 8,634,616 shares of common stock), respectively.

The estimated fair values of the Convertible loans were measured according to the Monte Carlo Model using the following assumptions:

	As of			As of
	March 31, 2024			December 31, 2023
Expected term (in years)		0.25			0.5
Expected average (Monte Carlo) volatility		83	%		213	%
Expected dividend yield		-			-
Risk-free interest rate		5.46	%		5.26	%
WACC		27	%		27	%

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 4

CONVERTIBLE LOANS AND WARRANTS (cont.)

The following table summarizes information relating to outstanding and exercisable warrants as of December 31, 2023:

Warrants Outstanding and Exercisable
Number of Warrants		Weighted Average Remaining Contractual life (in years)		Weighted Average Exercise Price		Valuation as of December 31, 2023
	8,334		2.16		0.6	$	23
	32,500		2.61		0.6	$	116
	7,000,000		0.46		0.015	$	203,718

The following table summarizes information relating to outstanding warrants as of March 31, 2024:

Warrants Outstanding
Number of Warrants		Weighted Average Remaining Contractual life (in years)		Weighted Average Exercise Price		Valuation as of March 31, 2024

	7,000,000		0.21		0.01024	$	71,702
	8,334		1.91		0.6	$	23
	32,500		2.36		0.6	$	116

The estimated fair values of the Warrants were measured according to the data as follows:

	As of			As of
	March 31, 2024			December 31, 2023
Expected term		0.21			0.46
Expected average volatility		87	%		224	%
Expected dividend yield		-			-
Risk-free interest rate		4.19	%		5.3	%
Common Stock Market Value	$	0.01024		$	0.015
Warrants rights outstanding measurement input	$	0.01024		$	0.015

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

NOTE 4

CONVERTIBLE LOANS AND WARRANTS (cont.)

The Convertible Loans at amortized cost changes consist of the following as of March 31, 2024 and December 31, 2023:

	March 31, 2024		December 31, 2023
	$000
Opening balance		796		-
Transition from convertible loans measured at fair value to measurement at amortized cost		-		530
Beneficial conversion feature		-		(66	)
Financial expenses related to transition from fair value measurement to amortized cost		-		304
Accrued interest through profit or loss		15		28
Closing balance		811		796

XML 24 R13.htm IDEA: XBRL DOCUMENT

STOCK BASED COMPENSATION

3 Months Ended

Mar. 31, 2024

Retirement Benefits [Abstract]

STOCK BASED COMPENSATION

NOTE 5 - STOCK BASED COMPENSATION

The table below depicts the number of options granted to employees and service providers:

SCHEDULE OF NUMBER OF OPTIONS

	Three months ended March 31, 2024
	Number of			Weighted average exercise price
	options			in USD

Options outstanding at January 1, 2024		62,349,647		$	0.0007
Options granted during the period		7,900,000		$	0.00373
Options exercised during the period*		(500,000	)	$	0.0001
Options outstanding at the end of period		69,749,647		$	0.00107
Options exercisable at the end of period		25,650,311		$	0.00136

*	A board member exercised his options into shares during the quarter

APPYEA INC.

NOTES TO THE FINANCIAL STATEMENTS

XML 25 R14.htm IDEA: XBRL DOCUMENT

SIGNIFICANT EVENTS DURING THE PERIOD

3 Months Ended

Mar. 31, 2024

Significant Events During Period

SIGNIFICANT EVENTS DURING THE PERIOD

NOTE 6 - SIGNIFICANT EVENTS DURING THE PERIOD

	C.	On January 1, 2024, the Company engaged with a note holder as a consultant. For his services, he was granted a stock option to purchase 5,000,000 of the Company’s Common Stock, valued at $74,675. Upon grant, the Options vest on a monthly basis, over a period of 12 months as of the Commencement Date ending December 31, 2024. The Option are exercisable at a per share exercise price of $0.0001.

	D.	During the first quarter of 2024, the company received an additional investment of $456,431 and registered shares to be issued from that investment in the amount of 7,500,000 common shares.

	E.	On August 11, 2022, a lawsuit was filed in the Tel Aviv Magistrate’s Court against our Chairman and majority shareholder, Boris Molchadsky, G.P.I.S Ltd., an entity controlled by Mr. Molchadsky, Nexsense, Inc. (the former shareholder of SleepX Ltd.) and SleepX, Ltd., our subsidiary (collectively, the “Defendants”) [Civil lawsuit number 25441-08-22]. The suit was filed by a fund operating out of Israel. A copy of the claim was served to the defendants only six months after it was submitted to court, on February 21, 2023. The lawsuit is based on the alleged breach of partnership and loan agreements as well as other related allegations, including violation of agreements reached in a mediation proceeding that took place in 2015. On July 24, 2023, the Defendants (except for Nexsense, Inc.) filed a statement of defense, denying the allegations and argued that the claim should be dismissed, due to the statute of limitations, lack of cause of action, lack of jurisdiction, delay in filing the claim, and respecting SleepX, also due to the lack of legal rivalry between SleepX and the plaintiff. Recently, the Magistrate’s Court in Tel Aviv accepted the request regarding lack of material jurisdiction, and the claim was then transferred to the economic department of the District Court in Tel Aviv. A preliminary hearing was held on February 14, 2024. The presiding judge did not rule on the preliminary pleadings and urged the parties to attempt mediation before the ruling. The parties are considering different mediators (which must be mutually agreed to) and following the selection of a mediator, the parties will schedule a date for the mediation. The Company cannot, at this stage, know the effects, if any, of these actions on its subsidiary SleepX and / or the Company, and accordingly, no provision was recorded.

XML 26 R15.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 7 - SUBSEQUENT EVENTS

	A.	On May 13, 2024, Mr. Neil Kline announced the company on his resignation from the board of directors of the company. In Parallel, Mr. Kline signed an advisor agreement with the company to serve as an advisor of the Board, and provide services related to the development of company future products, creating marketing tools for company needs, and assist with filings and projects of the company.

	B.	On May 14, 2024, the Board of the Company (the “Boad”) approved the conversion of outstanding amounts owed to its officers and directors for unpaid compensation for options of the Company’s common stock, as follows: Boris Molchadsky, the Company chairman, and Asaf Porat, the Company CFO, agreed to convert a portion their unpaid compensation into options for shares of the Company’s common stock at a per share conversion rate of $0.07 and $0.04, respectively, and Adi Shemer, the Company CEO, has agreed to convert the entire unpaid compensation to him into options for shares of the Company’s common stock at per share conversation date of $0.04, in each case under a Company compensation Plan to be approved by the Company and its shareholders and qualified under Sections 102 and 103 of the Israeli tax authorities (such being the “Qualified Equity Interests”). There remains outstanding unpaid compensation to each of Mr. Molchadsky and Porat in the amount of $70,000 and $50,000, respectively. It was agreed that the unpaid compensation which was not converted would be paid in 20 equal monthly instalments, subject to payment of payroll, social security and other taxes, commencing on the 30^th day following the earlier to occur of (i) the closing of an equity raise by the Company with proceeds to the Company of at least $1.5 million, (ii) the completion of seven consecutive (7) months positive cash flow for the Company in such amount as will allow the Company to cover its operating expenses and (iii) termination of employment by the Company of for any reason other than cause. As of April 1, 2024 the Company converted the outstanding amounts related to its officers and directors and issued 6,959,692 options, which are exercisable with an exercise ratio of 1:1.

	C.	In addition, the Board approved the issuance of stock option to purchase 6,000,000 shares of the Company’s common stock, at a per share exercise price of $0.0001, to Adi Shemer, the Company CEO. Under his terms of his employment agreement, Mr. Shemer is entitled to these options following the issuance by the Company of at least 100 million shares of common stock in respect of third-party investments in the Company, which was satisfied in February 2024. The options will vest in full on July 1, 2024. For the three-month ended March 31, 2024 the Company recorded an expense related to the issuance of $49,492 out of a total expense of $197,966.

XML 27 R16.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Policies)	Mar. 31, 2024
Accounting Policies [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Effective January 1, 2024, the Company adopted ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), which is intended to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. For convertible instruments, ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stocks, and enhances information transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share guidance on the basis of feedback from financial statement users. The adoption of this new accounting guidance did not have an effect on the consolidated financial statements. Effective January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326),” referred to herein as ASU 2016-13, which significantly changes how entities will account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaced the existing incurred loss model with an expected credit loss model that requires entities to estimate an expected lifetime credit loss on most financial assets and certain other instruments. Under ASU 2016-13 credit impairment is recognized as an allowance for credit losses, rather than as a direct write-down of the amortized cost basis of a financial asset. The impairment allowance is a valuation account deducted from the amortized cost basis of financial assets to present the net amount expected to be collected on the financial asset. Once the new pronouncement is adopted by the Company, the allowance for credit losses must be adjusted for management’s current estimate at each reporting date. The new guidance provides no threshold for recognition of impairment allowance. Therefore, entities must also measure expected credit losses on assets that have a low risk of loss. For instance, trade receivables that are either current or not yet due may not require an allowance reserve under current generally accepted accounting principles, but under the new standard, the Company will have to estimate an allowance for expected credit losses on trade receivables under ASU 2016-13. The Company determined the adoption of this new accounting guidance and the effect on its financial statements throughout the period until implementation, and have no impact on the financial statements. In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s financial statements.
Use of Estimates in Preparation of Financial Statements	Use of Estimates in Preparation of Financial Statements The preparation of consolidated financial statements in conformity with U.S. GAAP accounting principles requires management to make estimates and assumptions. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition	Revenue Recognition The Company recognizes revenue under ASC 606, Revenue Recognition at the amount to which it expects to be entitled when control of the products or services is transferred to its customers. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. Our contracts are typically governed by a customer purchase order. The contract generally specifies the delivery of what constitutes a single performance obligation. If an arrangement involves multiple performance obligations, the items are analyzed to determine the separate units of accounting, whether the items have value on a standalone basis and whether there is objective and reliable evidence of their standalone selling price. The total contract transaction price is allocated to the identified performance obligations based upon the relative standalone selling prices of the performance obligations. The standalone selling price is based on an observable price for services sold to other comparable customers. As discussed in more detail below, revenue is recognized when a customer obtains control of promised goods or services under the terms of a contract and is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. We do not have any material extended payment terms, as payment is due at or shortly after the time of the sale. Sales, value-added and other taxes collected concurrently with revenue producing activities are excluded from revenue. A contract liability is recognized as deferred revenue when we invoice customers, or receive customer cash payments, in advance of satisfying the related performance obligation(s) under the terms of a contract. Deferred revenue is recognized as revenue when we have satisfied the related performance obligation. We have one main revenue stream: wristband sales, with the AppySleep App. For this revenue stream, our performance obligations are satisfied at a point in time, and therefore, revenue is recognized at point in time when a customer takes control of the good or asset created by the service. Factors that may indicate transfer of control are when we have the right to receive payment for the good or service, when the legal title of the asset has been transferred, physical possession of the asset has been transferred, the customer obtains the significant risks and rewards of ownership of the asset, and the customer accepts the asset. For customers, control is transferred upon delivery. We leverage drop-ship shipments with our partners and suppliers to deliver wristbands to our customers without having to physically hold the inventory at our warehouses, thereby increasing efficiency and reducing costs. We recognize revenue for drop-ship arrangements on a gross basis as the principal in the transaction when the product is received by the customer because we control the product prior to transfer to the customer. We also assume primary responsibility for the fulfillment in the arrangement, we assume inventory risk if something were to happen to the hardware during shipping, we set the price of the product charged to the customer. The Company intend to recognize records reductions to Products net sales related to future product returns, price protection and other customer incentive programs based on the Company’s expectations and historical experience.

XML 28 R17.htm IDEA: XBRL DOCUMENT

RELATED PARTY BALANCES AND TRANSACTIONS (Tables)

3 Months Ended

Mar. 31, 2024

SCHEDULE OF BALANCE WITH RELATED PARTIES

	March 31, 2024		December 31, 2023
	In U.S. dollars in thousands

Liabilities:
Employees and payroll accruals		267		498
Related party payables		208		129
Short term loans		79		79

SCHEDULE OF TRANSACTION WITH RELATED PARTIES

	2024		2023
	For the three months ended March 31,
	2024		2023
	In U.S. dollars in thousands
Expenses:
Salaries and related cost (including stock-based compensation in the amount of $116,000 and $721,000, respectively)		190		1,067

XML 29 R18.htm IDEA: XBRL DOCUMENT

CONVERTIBLE LOANS AND WARRANTS (Tables)

3 Months Ended

Mar. 31, 2024

Class of Warrant or Right [Line Items]

SCHEDULE OF FAIR VALUE RECURRING BASIS

December 31, 2023	Level 1		Level 2		Level 3		Total
	In U.S. dollars
Assets
None		-		-		-		-

Liabilities
Convertible Loans At fair value		-		-		1,203		1,203
Financial liability				-		204		204

March 31, 2024	Level 1		Level 2		Level 3		Total
	In U.S. dollars
Assets
None		-		-		-		-

Liabilities
Convertible Loans At fair value		-		-		2,160		2,160
Financial liability				-		72		72

SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE

	March 31, 2024		December 31, 2023
	Convertible Loans at Fair Value
	March 31, 2024		December 31, 2023
	$000
Opening Balance, (including short term loans from related party which is also convertible)		1,203		2,257
Additional convertible loans (a)		-		153
Conversion of convertible loan (b)		-		(243	)
Decrease of notes purchased		-		(530	)
Change in fair value of convertible loans liability		957		(434	)
Closing balance		2,160		1,203

(a)

During the quarter ended March 31, 2024, and the year ended December 31, 2023, the Company raised a principal amount of nill and $152,750, respectively.

(b)

During the quarter ended March 31, 2024, and the year ended December 31, 2023 a total amount of nill and $242,538 (which were converted into 8,634,616 shares of common stock), respectively.

SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED

The estimated fair values of the Warrants were measured according to the data as follows:

	As of			As of
	March 31, 2024			December 31, 2023
Expected term		0.21			0.46
Expected average volatility		87	%		224	%
Expected dividend yield		-			-
Risk-free interest rate		4.19	%		5.3	%
Common Stock Market Value	$	0.01024		$	0.015
Warrants rights outstanding measurement input	$	0.01024		$	0.015

SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS

The following table summarizes information relating to outstanding and exercisable warrants as of December 31, 2023:

Warrants Outstanding and Exercisable
Number of Warrants		Weighted Average Remaining Contractual life (in years)		Weighted Average Exercise Price		Valuation as of December 31, 2023
	8,334		2.16		0.6	$	23
	32,500		2.61		0.6	$	116
	7,000,000		0.46		0.015	$	203,718

The following table summarizes information relating to outstanding warrants as of March 31, 2024:

Warrants Outstanding
Number of Warrants		Weighted Average Remaining Contractual life (in years)		Weighted Average Exercise Price		Valuation as of March 31, 2024

	7,000,000		0.21		0.01024	$	71,702
	8,334		1.91		0.6	$	23
	32,500		2.36		0.6	$	116

SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST

The Convertible Loans at amortized cost changes consist of the following as of March 31, 2024 and December 31, 2023:

	March 31, 2024		December 31, 2023
	$000
Opening balance		796		-
Transition from convertible loans measured at fair value to measurement at amortized cost		-		530
Beneficial conversion feature		-		(66	)
Financial expenses related to transition from fair value measurement to amortized cost		-		304
Accrued interest through profit or loss		15		28
Closing balance		811		796

Old CLA [Member]

Class of Warrant or Right [Line Items]

SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED

The estimated fair values of the Convertible loans were measured according to the Monte Carlo Model using the following assumptions:

	As of			As of
	March 31, 2024			December 31, 2023
Expected term (in years)		0.25			0.5
Expected average (Monte Carlo) volatility		83	%		213	%
Expected dividend yield		-			-
Risk-free interest rate		5.46	%		5.26	%
WACC		27	%		27	%

XML 30 R19.htm IDEA: XBRL DOCUMENT

STOCK BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2024

Consultants and Employees [Member]

SCHEDULE OF NUMBER OF OPTIONS

	Three months ended March 31, 2024
	Number of			Weighted average exercise price
	options			in USD

Options outstanding at January 1, 2024		62,349,647		$	0.0007
Options granted during the period		7,900,000		$	0.00373
Options exercised during the period*		(500,000	)	$	0.0001
Options outstanding at the end of period		69,749,647		$	0.00107
Options exercisable at the end of period		25,650,311		$	0.00136

*	A board member exercised his options into shares during the quarter

XML 31 R20.htm IDEA: XBRL DOCUMENT

GENERAL (Details Narrative) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ (7,570)	$ (6,326)
Stockholders' deficiency	$ (3,153)	$ (2,539)

- Definition

Amount of accumulated undistributed earnings (deficit).

+ References + Details

- Definition

Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2

+ Details

XML 32 R21.htm IDEA: XBRL DOCUMENT

SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Liabilities:
Employees and payroll accruals	$ 267	$ 498
Related party payables	208	129
Short term loans	$ 79	$ 79

XML 33 R22.htm IDEA: XBRL DOCUMENT

SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Related Party Transactions [Abstract]
Salaries and related cost (including stock-based compensation in the amount of $116,000 and $721,000, respectively)	$ 190	$ 1,067

XML 34 R23.htm IDEA: XBRL DOCUMENT

SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) (Parenthetical) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Related Party Transactions [Abstract]
Shared based compensation	$ 116,000	$ 721,000

XML 35 R24.htm IDEA: XBRL DOCUMENT

RELATED PARTY BALANCES AND TRANSACTIONS (Details Narrative)	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2024 ILS (₪)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 ILS (₪)
Noncontrolling Interest [Member] \| Tanooma Ltd [Member]
Related Party Transaction [Line Items]
Due to related parties current and noncurrent	$ 31,906	₪ 115,725		₪ 115,725
Nexense Technologies LTD [Member]
Related Party Transaction [Line Items]
Related-party transaction rate	5.18%
Nexense Technologies LTD [Member]
Related Party Transaction [Line Items]
Due from related parties			$ 47,623

- Definition

Amount of liabilities classified as other.

+ References + Details

XML 36 R25.htm IDEA: XBRL DOCUMENT

SCHEDULE OF FAIR VALUE RECURRING BASIS (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Platform Operator, Crypto Asset [Line Items]
Financial liability	$ 72	$ 204
Fair Value, Recurring [Member]
Platform Operator, Crypto Asset [Line Items]
Assets
Convertible Loans at fair value	2,160	1,203
Financial liability	72	204
Fair Value, Inputs, Level 1 [Member] \| Fair Value, Recurring [Member]
Platform Operator, Crypto Asset [Line Items]
Assets
Convertible Loans at fair value
Fair Value, Inputs, Level 2 [Member] \| Fair Value, Recurring [Member]
Platform Operator, Crypto Asset [Line Items]
Assets
Convertible Loans at fair value
Financial liability
Fair Value, Inputs, Level 3 [Member] \| Fair Value, Recurring [Member]
Platform Operator, Crypto Asset [Line Items]
Assets
Convertible Loans at fair value	2,160	1,203
Financial liability	$ 72	$ 204

XML 37 R26.htm IDEA: XBRL DOCUMENT

SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Mar. 31, 2024

Dec. 31, 2023

Convertible Loans And Warrants

Opening Balance, (including short term loans from related party which is also convertible)

$ 1,203

$ 2,257

Additional convertible loans

^[1]

153

Conversion of convertible loan

^[2]

(243)

Decrease of notes purchased

(530)

Change in fair value of convertible loans liability

957

(434)

Closing balance

$ 2,160

$ 1,203

[1]	During the quarter ended March 31, 2024, and the year ended December 31, 2023, the Company raised a principal amount of nill and $152,750, respectively.
[2]	During the quarter ended March 31, 2024, and the year ended December 31, 2023 a total amount of nill and $242,538 (which were converted into 8,634,616 shares of common stock), respectively.

XML 38 R27.htm IDEA: XBRL DOCUMENT

SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) (Parenthetical) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Convertible Loans And Warrants
Principal amount		$ 152,750
Converted amount		$ 242,538
Number of shares converted		8,634,616

XML 39 R28.htm IDEA: XBRL DOCUMENT

SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Class of Warrant or Right [Line Items]
Expected term	2 months 15 days	5 months 15 days
Measurement Input, Price Volatility [Member]
Class of Warrant or Right [Line Items]
Warrants rights outstanding measurement input	87	224
Measurement Input, Expected Dividend Rate [Member]
Class of Warrant or Right [Line Items]
Warrants rights outstanding measurement input
Measurement Input, Risk Free Interest Rate [Member]
Class of Warrant or Right [Line Items]
Warrants rights outstanding measurement input	4.19	5.3
Measurement Input Common Market Value [Member]
Class of Warrant or Right [Line Items]
Warrants rights outstanding measurement input	0.01024	0.015
Old CLA [Member]
Class of Warrant or Right [Line Items]
Expected term (in years)	3 months	6 months
Expected average (Monte Carlo) volatility	83.00%	213.00%
Expected dividend yield
Risk-free interest rate	5.46%	5.26%
WACC	27.00%	27.00%

XML 40 R29.htm IDEA: XBRL DOCUMENT

SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Weighted Average Remaining Contractual life (in years)	2 months 15 days	5 months 15 days
Warrant One [Member]
Warrants Outstanding and Exercisable, Number of Warrants	7,000,000	8,334
Weighted Average Remaining Contractual life (in years)	2 months 15 days	2 years 1 month 28 days
Warrants Outstanding and Exercisable, Weighted Average Exercise Price	$ 0.01024	$ 0.6
Warrants Outstanding and Exercisable, value	$ 71,702	$ 23
Warrant Two [Member]
Warrants Outstanding and Exercisable, Number of Warrants	8,334	32,500
Weighted Average Remaining Contractual life (in years)	1 year 10 months 28 days	2 years 7 months 9 days
Warrants Outstanding and Exercisable, Weighted Average Exercise Price	$ 0.6	$ 0.6
Warrants Outstanding and Exercisable, value	$ 23	$ 116
Warrant Three [Member]
Warrants Outstanding and Exercisable, Number of Warrants	32,500	7,000,000
Weighted Average Remaining Contractual life (in years)	2 years 4 months 9 days	5 months 15 days
Warrants Outstanding and Exercisable, Weighted Average Exercise Price	$ 0.6	$ 0.015
Warrants Outstanding and Exercisable, value	$ 116	$ 203,718

XML 41 R30.htm IDEA: XBRL DOCUMENT

SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Convertible Loans And Warrants
Opening balance	$ 796
Transition from convertible loans measured at fair value to measurement at amortized cost		530
Beneficial conversion feature		(66)
Financial expenses related to transition from fair value measurement to amortized cost		304
Accrued interest through profit or loss	15	28
Closing balance	$ 811	$ 796

XML 42 R31.htm IDEA: XBRL DOCUMENT

SCHEDULE OF NUMBER OF OPTIONS (Details) - Consultants and Employees [Member]

3 Months Ended

Mar. 31, 2024

$ / shares

Number of options, Outstanding balance | shares

62,349,647

Weighted average exercise price, Outstanding balance | $ / shares

$ 0.0007

Number of options, Granted | shares

7,900,000

Weighted average exercise price, Granted | $ / shares

$ 0.00373

Number of options, Exercised | shares

(500,000)

^[1]

Weighted average exercise price, Exercised | $ / shares

$ 0.0001

^[1]

Number of options, Outstanding balance | shares

69,749,647

Weighted average exercise price, Outstanding balance | $ / shares

$ 0.00107

Number of options, Exercisable balance | shares

25,650,311

Weighted average exercise price, Exercisable balance | $ / shares

$ 0.00136

[1]	A board member exercised his options into shares during the quarter

XML 43 R32.htm IDEA: XBRL DOCUMENT

STOCK BASED COMPENSATION (Details Narrative) - USD ($)	3 Months Ended
STOCK BASED COMPENSATION (Details Narrative) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Share based compensation	$ 172,000	$ 279,000
Chief Financial Officer And Advisor [Member]
Share based compensation	$ 147,000	$ 279,000

XML 44 R33.htm IDEA: XBRL DOCUMENT

SIGNIFICANT EVENTS DURING THE PERIOD (Details Narrative) - USD ($)		3 Months Ended
	Jan. 01, 2024	Mar. 31, 2024
Additional investment received		$ 456,431
Investment shares issued		7,500,000
Consultant [Member]
Stock option granted	2,300,000
Stock option granted, value	$ 34,350
Option vesting description	The Options are vested on a monthly basis, over a period of 30 months as of the commencement date ending June 30, 2026. The options are exercisable at a per share exercise price of $0.01
Share price	$ 0.01
Consultant One [Member]
Stock option granted	600,000
Stock option granted, value	$ 8,961
Option vesting description	The Options are vested on a monthly basis, over a period of 30 months as of the Commencement Date ending June 30, 2026. The Option are exercisable at a per share exercise price of $0.01
Share price	$ 0.01
Consultant Two [Member]
Stock option granted	5,000,000
Stock option granted, value	$ 74,675
Option vesting description	Upon grant, the Options vest on a monthly basis, over a period of 12 months as of the Commencement Date ending December 31, 2024. The Option are exercisable at a per share exercise price of $0.0001.
Share price	$ 0.0001

XML 45 R34.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS (Details Narrative) - USD ($)			3 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Jul. 01, 2024	May 14, 2024	Mar. 31, 2024	Mar. 31, 2023	Apr. 01, 2024	Dec. 31, 2023
Subsequent Event [Line Items]
Proceeds from issuance of common stock			$ 381,000
Common stock exercise price			$ 0.0001			$ 0.0001
Issuance related to expense			$ 49,492
Stock issuance total expense			$ 197,966
Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from issuance of common stock		$ 1,500,000
Adi Shemer [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Number of shares issued	6,000,000
Common stock exercise price	$ 0.0001
Adi Shemer [Member] \| Subsequent Event [Member] \| Minimum [Member]
Subsequent Event [Line Items]
Number of shares issued	100,000,000
Officer And Director [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Options outstanding					6,959,692
Common Stock [Member] \| Boris Molchadsky [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Share conversion rate		$ 0.07
Outstanding unpaid compensation		$ 70,000,000
Common Stock [Member] \| Asaf Porat [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Share conversion rate		$ 0.04
Outstanding unpaid compensation		$ 50,000,000
Common Stock [Member] \| Adi Shemer [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Share conversion rate		$ 0.04

EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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Ł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end XML 47 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 102 171 1 true 34 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://appyea.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://appyea.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://appyea.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://appyea.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Deficiency (Unaudited) Sheet http://appyea.com/role/StatementsOfChangesInDeficiency Condensed Consolidated Statements of Changes in Deficiency (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://appyea.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995512 - Disclosure - GENERAL Sheet http://appyea.com/role/General GENERAL Notes 9 false false R10.htm 995513 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://appyea.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 995514 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS Sheet http://appyea.com/role/RelatedPartyBalancesAndTransactions RELATED PARTY BALANCES AND TRANSACTIONS Notes 11 false false R12.htm 995515 - Disclosure - CONVERTIBLE LOANS AND WARRANTS Sheet http://appyea.com/role/ConvertibleLoansAndWarrants CONVERTIBLE LOANS AND WARRANTS Notes 12 false false R13.htm 995516 - Disclosure - STOCK BASED COMPENSATION Sheet http://appyea.com/role/StockBasedCompensation STOCK BASED COMPENSATION Notes 13 false false R14.htm 995517 - Disclosure - SIGNIFICANT EVENTS DURING THE PERIOD Sheet http://appyea.com/role/SignificantEventsDuringPeriod SIGNIFICANT EVENTS DURING THE PERIOD Notes 14 false false R15.htm 995518 - Disclosure - SUBSEQUENT EVENTS Sheet http://appyea.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 995519 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://appyea.com/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 995520 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables) Sheet http://appyea.com/role/RelatedPartyBalancesAndTransactionsTables RELATED PARTY BALANCES AND TRANSACTIONS (Tables) Tables http://appyea.com/role/RelatedPartyBalancesAndTransactions 17 false false R18.htm 995521 - Disclosure - CONVERTIBLE LOANS AND WARRANTS (Tables) Sheet http://appyea.com/role/ConvertibleLoansAndWarrantsTables CONVERTIBLE LOANS AND WARRANTS (Tables) Tables http://appyea.com/role/ConvertibleLoansAndWarrants 18 false false R19.htm 995522 - Disclosure - STOCK BASED COMPENSATION (Tables) Sheet http://appyea.com/role/StockBasedCompensationTables STOCK BASED COMPENSATION (Tables) Tables http://appyea.com/role/StockBasedCompensation 19 false false R20.htm 995523 - Disclosure - GENERAL (Details Narrative) Sheet http://appyea.com/role/GeneralDetailsNarrative GENERAL (Details Narrative) Details http://appyea.com/role/General 20 false false R21.htm 995524 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) Sheet http://appyea.com/role/ScheduleOfBalanceWithRelatedPartiesDetails SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) Details 21 false false R22.htm 995525 - Disclosure - SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) Sheet http://appyea.com/role/ScheduleOfTransactionWithRelatedPartiesDetails SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) Details 22 false false R23.htm 995526 - Disclosure - SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) (Parenthetical) Sheet http://appyea.com/role/ScheduleOfTransactionWithRelatedPartiesDetailsParenthetical SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) (Parenthetical) Details 23 false false R24.htm 995527 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details Narrative) Sheet http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative RELATED PARTY BALANCES AND TRANSACTIONS (Details Narrative) Details http://appyea.com/role/RelatedPartyBalancesAndTransactionsTables 24 false false R25.htm 995528 - Disclosure - SCHEDULE OF FAIR VALUE RECURRING BASIS (Details) Sheet http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails SCHEDULE OF FAIR VALUE RECURRING BASIS (Details) Details 25 false false R26.htm 995529 - Disclosure - SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) Sheet http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetails SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) Details 26 false false R27.htm 995530 - Disclosure - ??SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) (Parenthetical) Sheet http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetailsParenthetical SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) (Parenthetical) Details 27 false false R28.htm 995531 - Disclosure - SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED (Details) Sheet http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED (Details) Details 28 false false R29.htm 995532 - Disclosure - SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS (Details) Sheet http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS (Details) Details 29 false false R30.htm 995533 - Disclosure - SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST (Details) Sheet http://appyea.com/role/ScheduleOfConvertibleLoansAmortizedCostDetails SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST (Details) Details 30 false false R31.htm 995534 - Disclosure - SCHEDULE OF NUMBER OF OPTIONS (Details) Sheet http://appyea.com/role/ScheduleOfNumberOfOptionsDetails SCHEDULE OF NUMBER OF OPTIONS (Details) Details 31 false false R32.htm 995535 - Disclosure - STOCK BASED COMPENSATION (Details Narrative) Sheet http://appyea.com/role/StockBasedCompensationDetailsNarrative STOCK BASED COMPENSATION (Details Narrative) Details http://appyea.com/role/StockBasedCompensationTables 32 false false R33.htm 995536 - Disclosure - SIGNIFICANT EVENTS DURING THE PERIOD (Details Narrative) Sheet http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative SIGNIFICANT EVENTS DURING THE PERIOD (Details Narrative) Details http://appyea.com/role/SignificantEventsDuringPeriod 33 false false R34.htm 995537 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://appyea.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://appyea.com/role/SubsequentEvents 34 false false All Reports Book All Reports [dq-60548-EntityAddressPostalZipCode-Missing] Submission type 10-Q should have a non-empty value for EntityAddressPostalZipCode in the Required Context. form10-q.htm apyp-20240331.xsd apyp-20240331_cal.xml apyp-20240331_def.xml apyp-20240331_lab.xml apyp-20240331_pre.xml form10-q.htm http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 53 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "APYP", "nsuri": "http://appyea.com/20240331", "dts": { "schema": { "local": [ "apyp-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "apyp-20240331_cal.xml" ] }, "definitionLink": { "local": [ "apyp-20240331_def.xml" ] }, "labelLink": { "local": [ "apyp-20240331_lab.xml" ] }, "presentationLink": { "local": [ "apyp-20240331_pre.xml" ] }, "inline": { "local": [ "form10-q.htm" ] } }, "keyStandard": 147, "keyCustom": 24, "axisStandard": 11, "axisCustom": 0, "memberStandard": 16, "memberCustom": 17, "hidden": { "total": 101, "http://fasb.org/us-gaap/2024": 77, "http://appyea.com/20240331": 20, "http://xbrl.sec.gov/dei/2024": 4 }, "contextCount": 102, "entityCount": 1, "segmentCount": 34, "elementCount": 377, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 382, "http://xbrl.sec.gov/dei/2024": 25, "http://xbrl.sec.gov/ecd/2024": 4 }, "report": { "R1": { "role": "http://appyea.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://appyea.com/role/BalanceSheets", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R3": { "role": "http://appyea.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R4": { "role": "http://appyea.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R5": { "role": "http://appyea.com/role/StatementsOfChangesInDeficiency", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Deficiency (Unaudited)", "shortName": "Condensed Consolidated Statements of Changes in Deficiency (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R6": { "role": "http://appyea.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://appyea.com/role/General", "longName": "995512 - Disclosure - GENERAL", "shortName": "GENERAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://appyea.com/role/SignificantAccountingPolicies", "longName": "995513 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://appyea.com/role/RelatedPartyBalancesAndTransactions", "longName": "995514 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://appyea.com/role/ConvertibleLoansAndWarrants", "longName": "995515 - Disclosure - CONVERTIBLE LOANS AND WARRANTS", "shortName": "CONVERTIBLE LOANS AND WARRANTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "APYP:ConvertibleLoansAndWaarantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "APYP:ConvertibleLoansAndWaarantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://appyea.com/role/StockBasedCompensation", "longName": "995516 - Disclosure - STOCK BASED COMPENSATION", "shortName": "STOCK BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://appyea.com/role/SignificantEventsDuringPeriod", "longName": "995517 - Disclosure - SIGNIFICANT EVENTS DURING THE PERIOD", "shortName": "SIGNIFICANT EVENTS DURING THE PERIOD", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "APYP:SignificantEventsDuringThePeriodTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "APYP:SignificantEventsDuringThePeriodTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://appyea.com/role/SubsequentEvents", "longName": "995518 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://appyea.com/role/SignificantAccountingPoliciesPolicies", "longName": "995519 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://appyea.com/role/RelatedPartyBalancesAndTransactionsTables", "longName": "995520 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "APYP:ScheduleOfBalancesWithRelatedPartiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "APYP:ScheduleOfBalancesWithRelatedPartiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://appyea.com/role/ConvertibleLoansAndWarrantsTables", "longName": "995521 - Disclosure - CONVERTIBLE LOANS AND WARRANTS (Tables)", "shortName": "CONVERTIBLE LOANS AND WARRANTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://appyea.com/role/StockBasedCompensationTables", "longName": "995522 - Disclosure - STOCK BASED COMPENSATION (Tables)", "shortName": "STOCK BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_custom_ConsultantsAndEmployeesMember", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_ConsultantsAndEmployeesMember", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://appyea.com/role/GeneralDetailsNarrative", "longName": "995523 - Disclosure - GENERAL (Details Narrative)", "shortName": "GENERAL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "20", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": null }, "R21": { "role": "http://appyea.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "longName": "995524 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details)", "shortName": "SCHEDULE OF BALANCE WITH RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "APYP:ScheduleOfBalancesWithRelatedPartiesTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "APYP:ScheduleOfBalancesWithRelatedPartiesTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://appyea.com/role/ScheduleOfTransactionWithRelatedPartiesDetails", "longName": "995525 - Disclosure - SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details)", "shortName": "SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SalariesWagesAndOfficersCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SalariesWagesAndOfficersCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://appyea.com/role/ScheduleOfTransactionWithRelatedPartiesDetailsParenthetical", "longName": "995526 - Disclosure - SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) (Parenthetical)", "shortName": "SCHEDULE OF TRANSACTION WITH RELATED PARTIES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R24": { "role": "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative", "longName": "995527 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_TanoomaLtdMember_us-gaap_NoncontrollingInterestMember", "name": "us-gaap:OtherLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_TanoomaLtdMember_us-gaap_NoncontrollingInterestMember", "name": "us-gaap:OtherLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R25": { "role": "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails", "longName": "995528 - Disclosure - SCHEDULE OF FAIR VALUE RECURRING BASIS (Details)", "shortName": "SCHEDULE OF FAIR VALUE RECURRING BASIS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_FairValueMeasurementsRecurringMember", "name": "us-gaap:ConvertibleDebtFairValueDisclosures", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R26": { "role": "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetails", "longName": "995529 - Disclosure - SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details)", "shortName": "SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ConvertibleDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ConvertibleDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R27": { "role": "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetailsParenthetical", "longName": "995530 - Disclosure - \u00a0SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) (Parenthetical)", "shortName": "SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R28": { "role": "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails", "longName": "995531 - Disclosure - SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED (Details)", "shortName": "SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "APYP:ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_MeasurementInputPriceVolatilityMember", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "APYP:ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R29": { "role": "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails", "longName": "995532 - Disclosure - SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS (Details)", "shortName": "SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "APYP:ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_WarrantOneMember", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R30": { "role": "http://appyea.com/role/ScheduleOfConvertibleLoansAmortizedCostDetails", "longName": "995533 - Disclosure - SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST (Details)", "shortName": "SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "APYP:ConvertibleAmortizedCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "APYP:ScheduleOfConvertibleLoansAmortizedCostsTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31", "name": "APYP:TransitionFromConvertibleLoansMeasuredAtFairValueToMeasurementAtAmortizedCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "APYP:ScheduleOfConvertibleLoansAmortizedCostsTableTextBlock", "APYP:ConvertibleLoansAndWaarantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R31": { "role": "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "longName": "995534 - Disclosure - SCHEDULE OF NUMBER OF OPTIONS (Details)", "shortName": "SCHEDULE OF NUMBER OF OPTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_ConsultantsAndEmployeesMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_ConsultantsAndEmployeesMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R32": { "role": "http://appyea.com/role/StockBasedCompensationDetailsNarrative", "longName": "995535 - Disclosure - STOCK BASED COMPENSATION (Details Narrative)", "shortName": "STOCK BASED COMPENSATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_ChiefFinancialOfficerAndAdvisorMember", "name": "us-gaap:ShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R33": { "role": "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative", "longName": "995536 - Disclosure - SIGNIFICANT EVENTS DURING THE PERIOD (Details Narrative)", "shortName": "SIGNIFICANT EVENTS DURING THE PERIOD (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InvestmentCompanyAmountReceivedToNavExcessLess", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "APYP:SignificantEventsDuringThePeriodTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InvestmentCompanyAmountReceivedToNavExcessLess", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "APYP:SignificantEventsDuringThePeriodTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R34": { "role": "http://appyea.com/role/SubsequentEventsDetailsNarrative", "longName": "995537 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PaymentsOfStockIssuanceCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableOtherCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableOtherCurrent", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other accounts payable", "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r35" ] }, "us-gaap_AccountsPayableTradeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableTradeCurrent", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Trade payables", "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r10", "r35" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivables", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r535" ] }, "APYP_AccruedInterestInProfitAndLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "AccruedInterestInProfitAndLoss", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAmortizedCostDetails" ], "lang": { "en-us": { "role": { "label": "Accrued interest through profit or loss", "documentation": "Accrued interest through profit or loss." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r481" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r45", "r421", "r570" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r319", "r525", "r526", "r527", "r528", "r542", "r571" ] }, "APYP_AdiShemerMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "AdiShemerMember", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Adi Shemer [Member]" } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r487" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r487" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r487" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r487" ] }, "us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Additional convertible loans", "documentation": "Amount of increase (decrease) in additional paid-in capital (APIC) from recognition of substantial premium at which convertible debt instrument is issued." } } }, "auth_ref": [ "r165" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Share based Compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r27", "r28", "r182" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r452", "r463", "r473", "r498" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r455", "r466", "r476", "r501" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r487" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r494" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r456", "r467", "r477", "r494", "r502", "r506", "r514" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://appyea.com/role/ScheduleOfTransactionWithRelatedPartiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Shared based compensation", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r209", "r210" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r459" ] }, "APYP_AsafPoratMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "AsafPoratMember", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Asaf Porat [Member]" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets [Default Label]", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r67", "r78", "r93", "r107", "r132", "r134", "r140", "r141", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r226", "r230", "r250", "r287", "r345", "r401", "r402", "r421", "r433", "r539", "r540", "r555" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r90", "r96", "r107", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r226", "r230", "r250", "r421", "r539", "r540", "r555" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Assets", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r242", "r243", "r415" ] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current asset", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r107", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r226", "r230", "r250", "r539", "r540", "r555" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r459" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "auth_ref": [ "r509" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r510" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r505" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r505" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method" } } }, "auth_ref": [ "r505" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r505" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r505" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined" } } }, "auth_ref": [ "r505" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Securities" } } }, "auth_ref": [ "r508" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r507" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r506" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r506" ] }, "APYP_BorisMolchadskyMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "BorisMolchadskyMember", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Boris Molchadsky [Member]", "documentation": "Boris Molchadsky [Member]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r13", "r92", "r395" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r13", "r56", "r105" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Change in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r56" ] }, "APYP_ChangeInFairValueOfConvertibleLoansAndWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "ChangeInFairValueOfConvertibleLoansAndWarrantLiability", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Change in fair value of convertible loans and warrant liability", "documentation": "Change in fair value of convertible loans and warrant liability." } } }, "auth_ref": [] }, "APYP_ChangeInFairValueOfConvertibleLoansLiabilityThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "ChangeInFairValueOfConvertibleLoansLiabilityThroughProfitOrLoss", "crdr": "debit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of convertible loans liability", "documentation": "Change in fair value of convertible loans liability through profit or loss.", "label": "ChangeInFairValueOfConvertibleLoansLiabilityThroughProfitOrLoss" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r485" ] }, "APYP_ChiefFinancialOfficerAndAdvisorMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "ChiefFinancialOfficerAndAdvisorMember", "presentation": [ "http://appyea.com/role/StockBasedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer And Advisor [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables", "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables", "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding and Exercisable, Weighted Average Exercise Price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r169" ] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables", "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding and Exercisable, Number of Warrants", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables", "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame." } } }, "auth_ref": [ "r25" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r486" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r486" ] }, "APYP_CommonStockConvertibleConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://appyea.com/20240331", "localname": "CommonStockConvertibleConversionPrice", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share conversion rate" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency", "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r423", "r424", "r425", "r427", "r428", "r429", "r430", "r525", "r526", "r528", "r542", "r568", "r571" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://appyea.com/role/BalanceSheetsParenthetical", "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "verboseLabel": "Common stock exercise price", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r44" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.0001 par value", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r44", "r291", "r421" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r491" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r490" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r492" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r489" ] }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "presentation": [ "http://appyea.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "STOCK BASED COMPENSATION", "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans." } } }, "auth_ref": [ "r62", "r63", "r64", "r65" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "APYP_ConsultantMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "ConsultantMember", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consultant [Member]", "documentation": "Consultant [Member]" } } }, "auth_ref": [] }, "APYP_ConsultantOneMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "ConsultantOneMember", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consultant One [Member]" } } }, "auth_ref": [] }, "APYP_ConsultantTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "ConsultantTwoMember", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consultant Two [Member]" } } }, "auth_ref": [] }, "APYP_ConsultantsAndEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "ConsultantsAndEmployeesMember", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "http://appyea.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Consultants and Employees [Member]", "documentation": "Consultants and Employees [Member]" } } }, "auth_ref": [] }, "APYP_ConversionOfConvertibleLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "ConversionOfConvertibleLoan", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible loan", "documentation": "Conversion of convertible loan." } } }, "auth_ref": [] }, "APYP_ConvertibleAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "ConvertibleAmortizedCost", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAmortizedCostDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Opening balance", "periodEndLabel": "Closing balance", "documentation": "Convertible loans at amortized cost.", "label": "ConvertibleAmortizedCost" } } }, "auth_ref": [] }, "APYP_ConvertibleAmortizedCostCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "ConvertibleAmortizedCostCurrent", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible loans at amortized cost", "documentation": "Convertible loans at amortized cost." } } }, "auth_ref": [] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Opening Balance, (including short term loans from related party which is also convertible)", "periodEndLabel": "Closing balance", "label": "Convertible Debt", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r9", "r70", "r565" ] }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleDebtFairValueDisclosures", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Loans at fair value", "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock." } } }, "auth_ref": [ "r544", "r545", "r546", "r547", "r548" ] }, "us-gaap_ConvertibleDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleDebtTableTextBlock", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE", "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount." } } }, "auth_ref": [] }, "APYP_ConvertibleLoansAndWaarantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://appyea.com/20240331", "localname": "ConvertibleLoansAndWaarantsTextBlock", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrants" ], "lang": { "en-us": { "role": { "label": "CONVERTIBLE LOANS AND WARRANTS", "documentation": "Convertible Loans And Waarants [Text Block]" } } }, "auth_ref": [] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible loans \u2013 At fair value", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r37" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost of sales", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r52", "r107", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r250", "r401", "r539" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Converted amount", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r14", "r15" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Number of shares converted", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r14", "r15" ] }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAmortizedCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Beneficial conversion feature", "label": "Debt Instrument, Convertible, Beneficial Conversion Feature", "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date." } } }, "auth_ref": [ "r20" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Principal amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r164", "r258", "r259", "r404", "r405", "r420" ] }, "APYP_DecreaseOfNotesPurchased": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "DecreaseOfNotesPurchased", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAtFairValueDetails" ], "lang": { "en-us": { "role": { "label": "Decrease of notes purchased", "documentation": "Decrease of notes purchased." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r3", "r132", "r137", "r141", "r401", "r402" ] }, "APYP_DisclosureConvertibleLoansAndWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://appyea.com/20240331", "localname": "DisclosureConvertibleLoansAndWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Convertible Loans And Warrants", "verboseLabel": "Schedule Of Convertible Loans At Fair Value", "terseLabel": "Schedule Of Convertible Loans At Fair Value Details" } } }, "auth_ref": [] }, "APYP_DisclosureSignificantEventsDuringPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "http://appyea.com/20240331", "localname": "DisclosureSignificantEventsDuringPeriodAbstract", "lang": { "en-us": { "role": { "label": "Significant Events During Period" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r447" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r445", "r447", "r459" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r446" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r434" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r447" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r447" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r480" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r437" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Loss per Common Share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Loss Per Common Share: Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r102", "r115", "r116", "r117", "r118", "r119", "r120", "r124", "r126", "r128", "r129", "r130", "r131", "r221", "r224", "r239", "r240", "r284", "r301", "r398" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Loss Per Common Share: Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r102", "r115", "r116", "r117", "r118", "r119", "r120", "r126", "r128", "r129", "r130", "r131", "r221", "r224", "r239", "r240", "r284", "r301", "r398" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Foreign exchange on Cash and cash equivalents", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r552" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Employees and payroll accruals", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r37" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r440" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r436" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r436" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r521" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r436" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r518" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r459" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r436" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r436" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r436" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r436" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r519" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative", "http://appyea.com/role/StatementsOfChangesInDeficiency", "http://appyea.com/role/SubsequentEventsDetailsNarrative", "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r6", "r87", "r99", "r100", "r101", "r110", "r111", "r112", "r114", "r119", "r121", "r123", "r133", "r147", "r148", "r149", "r170", "r215", "r216", "r218", "r219", "r220", "r222", "r223", "r224", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r251", "r252", "r253", "r254", "r255", "r256", "r260", "r262", "r264", "r300", "r305", "r306", "r307", "r319", "r375" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r488" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r452", "r463", "r473", "r498" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r449", "r460", "r470", "r495" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r494" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUE RECURRING BASIS", "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity." } } }, "auth_ref": [ "r415", "r543", "r544", "r549" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r166", "r174", "r175", "r176", "r177", "r178", "r179", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r276", "r277", "r278", "r404", "r405", "r407", "r408", "r409", "r415", "r416" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r242", "r243", "r244", "r246", "r415", "r546", "r550" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r166", "r174", "r179", "r243", "r248", "r276", "r407", "r408", "r409", "r415" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r166", "r174", "r179", "r243", "r244", "r248", "r277", "r404", "r405", "r407", "r408", "r409", "r415" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r166", "r174", "r175", "r176", "r177", "r178", "r179", "r243", "r244", "r245", "r246", "r248", "r278", "r404", "r405", "r407", "r408", "r409", "r415", "r416" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "auth_ref": [ "r242", "r243", "r244", "r246", "r415", "r546", "r550" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r166", "r174", "r175", "r176", "r177", "r178", "r179", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r276", "r277", "r278", "r404", "r405", "r407", "r408", "r409", "r415", "r416" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r415", "r543", "r544", "r545", "r546", "r547", "r550" ] }, "APYP_FinancialExpensesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "FinancialExpensesNet", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Financial expenses, net", "documentation": "Financial expenses, net." } } }, "auth_ref": [] }, "APYP_FinancialExpensesRelatedToTransitionFromFairValueMeasurementToAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "FinancialExpensesRelatedToTransitionFromFairValueMeasurementToAmortizedCost", "crdr": "debit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAmortizedCostDetails" ], "lang": { "en-us": { "role": { "label": "Financial expenses related to transition from fair value measurement to amortized cost", "documentation": "Financial expenses related to transition from fair value measurement to amortized cost." } } }, "auth_ref": [] }, "APYP_FinancialIncomeNetIncludingChangesInConvertibleLoansAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "FinancialIncomeNetIncludingChangesInConvertibleLoansAndWarrants", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of convertible loans and warrant liability", "label": "FinancialIncomeNetIncludingChangesInConvertibleLoansAndWarrants" } } }, "auth_ref": [] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets", "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Financial liability at fair value", "verboseLabel": "Financial liability", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [ "r543", "r544", "r548" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r283", "r537" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r456", "r467", "r477", "r502" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r456", "r467", "r477", "r502" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r456", "r467", "r477", "r502" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r456", "r467", "r477", "r502" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r456", "r467", "r477", "r502" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "General and administrative expenses", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r54", "r355" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r50", "r52", "r77", "r107", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r250", "r400", "r401", "r529", "r530", "r531", "r532", "r533", "r539" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income tax benefit", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r51", "r73", "r77", "r285", "r297", "r400", "r401", "r529", "r530", "r531", "r532", "r533" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income tax benefit", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r79", "r85", "r122", "r123", "r132", "r138", "r141", "r213", "r214", "r217", "r302", "r412" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payables", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r2" ] }, "APYP_IncreaseDecreaseInAccountsPayableToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "IncreaseDecreaseInAccountsPayableToRelatedParties", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payables \u2013 related party", "documentation": "Accounts payable \u2013 related party." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r523" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r456", "r467", "r477", "r494", "r502", "r506", "r514" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r512" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r448", "r517" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r448", "r517" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r448", "r517" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r95", "r396", "r421" ] }, "us-gaap_InvestmentCompanyAmountReceivedToNavExcessLess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentCompanyAmountReceivedToNavExcessLess", "crdr": "debit", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Additional investment received", "documentation": "Amount received for shares issued in excess of (less than) net asset value (NAV) of same class of security before sale." } } }, "auth_ref": [ "r312" ] }, "us-gaap_InvestmentOwnedBalanceShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentOwnedBalanceShares", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment shares issued", "documentation": "Number of shares of investment owned." } } }, "auth_ref": [ "r321", "r322", "r382", "r386", "r388", "r425" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r9", "r36", "r37", "r38", "r39", "r40", "r41", "r42", "r107", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r227", "r230", "r231", "r250", "r331", "r399", "r433", "r539", "r555", "r556" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAbstract", "presentation": [ "http://appyea.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities:" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and deficiency", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r49", "r72", "r294", "r421", "r524", "r536", "r551" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND DEFICIENCY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r38", "r91", "r107", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r227", "r230", "r231", "r250", "r421", "r539", "r555", "r556" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r486" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r486" ] }, "APYP_MeasurementInputCommonMarketValueMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "MeasurementInputCommonMarketValueMember", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Common Market Value [Member]", "documentation": "Measurement Input Common Market Value [Member]" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputExpectedDividendRateMember", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Dividend Rate [Member]", "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year." } } }, "auth_ref": [ "r545", "r546", "r547" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r416", "r545", "r546", "r547" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r545", "r546", "r547" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r244", "r245", "r246", "r416" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r244", "r245", "r246", "r416" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r151", "r152", "r153", "r154", "r181", "r211", "r246", "r281", "r303", "r304", "r310", "r323", "r324", "r381", "r383", "r384", "r385", "r387", "r391", "r392", "r403", "r406", "r410", "r416", "r417", "r418", "r422", "r541", "r557", "r558", "r559", "r560", "r561", "r562" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r48", "r71", "r107", "r146", "r155", "r157", "r158", "r159", "r162", "r163", "r250", "r293", "r334" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r505" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r513" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r487" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NatureOfOperations", "presentation": [ "http://appyea.com/role/General" ], "lang": { "en-us": { "role": { "label": "GENERAL", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r80", "r86" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r104" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r104" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r56", "r57", "r58" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://appyea.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows", "http://appyea.com/role/StatementsOfChangesInDeficiency", "http://appyea.com/role/StatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable to AppYea Inc.", "label": "Net loss", "verboseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r53", "r58", "r74", "r89", "r97", "r98", "r101", "r107", "r113", "r115", "r116", "r117", "r118", "r119", "r122", "r123", "r127", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r221", "r224", "r240", "r250", "r299", "r353", "r373", "r374", "r431", "r539" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://appyea.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "APYP_NexenseTechnologiesLTDMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "NexenseTechnologiesLTDMember", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nexense Technologies LTD [Member]", "documentation": "Nexense Technologies LTD [Member]" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r486" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r484" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r483" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r513" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r513" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestMember", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative", "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r30", "r170", "r525", "r526", "r527", "r528", "r571" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Financial income (expenses), net", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r55" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesPayableCurrent", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Related party payables", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r36", "r37" ] }, "APYP_OfficerAndDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "OfficerAndDirectorMember", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Officer And Director [Member]" } } }, "auth_ref": [] }, "APYP_OldCLAMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "OldCLAMember", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables", "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Old CLA [Member]", "documentation": "Old CLA [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating loss", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r77", "r400", "r529", "r530", "r531", "r532", "r533" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Due to related parties current and noncurrent", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r69", "r288", "r327", "r328", "r433", "r566", "r569" ] }, "us-gaap_OtherNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNotesPayableCurrent", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Short term loans", "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r37" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r486" ] }, "us-gaap_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Due from related parties", "documentation": "Amount due from parties in nontrade transactions, classified as other." } } }, "auth_ref": [ "r94", "r340", "r402", "r567" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other accounts receivables", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r447" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r454", "r465", "r475", "r500" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Amount" } } }, "auth_ref": [ "r457", "r468", "r478", "r503" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r457", "r468", "r478", "r503" ] }, "APYP_OutstandingUnpaidCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "OutstandingUnpaidCompensation", "crdr": "debit", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Outstanding unpaid compensation" } } }, "auth_ref": [] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ParentMember", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r482" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance related to expense", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r12" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r485" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r485" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r484" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r487" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r483" ] }, "us-gaap_PercentageOfWeightedAverageCostInventory": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PercentageOfWeightedAverageCostInventory", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "WACC", "label": "Percentage of Weighted Average Cost Inventory", "documentation": "The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods." } } }, "auth_ref": [] }, "srt_PlatformOperatorCryptoAssetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "PlatformOperatorCryptoAssetLineItems", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto Asset [Line Items]" } } }, "auth_ref": [ "r150" ] }, "srt_PlatformOperatorCryptoAssetTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "PlatformOperatorCryptoAssetTable", "presentation": [ "http://appyea.com/role/ScheduleOfFairValueRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Platform Operator, Crypto Asset [Table]" } } }, "auth_ref": [ "r150" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r484" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r441" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r443" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockMember", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r423", "r424", "r427", "r428", "r429", "r430", "r568", "r571" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://appyea.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r43", "r168" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock, $0.0001 par value", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r43", "r290", "r421" ] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from convertible Note received, net of issuance expenses", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows", "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of Common Stock", "verboseLabel": "Proceeds from issuance of common stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromStockPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromStockPlans", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds on account of Shares to be issued", "documentation": "The cash inflow associated with the amount received from the stock plan during the period." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r89", "r97", "r98", "r103", "r107", "r113", "r119", "r122", "r123", "r146", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r221", "r224", "r225", "r228", "r229", "r240", "r250", "r285", "r298", "r318", "r353", "r373", "r374", "r413", "r414", "r432", "r522", "r539" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r4", "r263", "r286", "r296", "r421" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r482" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r482" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r151", "r152", "r153", "r154", "r173", "r181", "r205", "r206", "r207", "r211", "r246", "r279", "r280", "r281", "r303", "r304", "r310", "r323", "r324", "r381", "r383", "r384", "r385", "r387", "r391", "r392", "r403", "r406", "r410", "r416", "r417", "r418", "r419", "r422", "r425", "r538", "r541", "r546", "r558", "r559", "r560", "r561", "r562" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "auth_ref": [ "r151", "r152", "r153", "r154", "r173", "r181", "r205", "r206", "r207", "r211", "r246", "r279", "r280", "r281", "r303", "r304", "r310", "r323", "r324", "r381", "r383", "r384", "r385", "r387", "r391", "r392", "r403", "r406", "r410", "r416", "r417", "r418", "r419", "r422", "r425", "r538", "r541", "r546", "r558", "r559", "r560", "r561", "r562" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r449", "r460", "r470", "r495" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://appyea.com/role/BalanceSheets", "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r145", "r180", "r268", "r269", "r289", "r295", "r326", "r327", "r328", "r329", "r330", "r350", "r352", "r380" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r108", "r109", "r268", "r269", "r270", "r271", "r289", "r295", "r326", "r327", "r328", "r329", "r330", "r350", "r352", "r380" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r268", "r269", "r554" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r145", "r356", "r357", "r360" ] }, "us-gaap_RelatedPartyTransactionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionRate", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related-party transaction rate", "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://appyea.com/role/BalanceSheets", "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r145", "r180", "r268", "r269", "r289", "r295", "r326", "r327", "r328", "r329", "r330", "r350", "r352", "r380", "r554" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY BALANCES AND TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r265", "r266", "r267", "r269", "r272", "r314", "r315", "r316", "r358", "r359", "r360", "r378", "r379" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Research and development expenses", "label": "Research and Development Expense", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r212", "r393", "r401", "r563" ] }, "APYP_ResearchAndDevelopmentExpensesCapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "ResearchAndDevelopmentExpensesCapitalization", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Research and development expenses capitalization", "documentation": "Research and development expenses capitalization.", "label": "Research and development expenses capitalization" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r450", "r461", "r471", "r496" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r451", "r462", "r472", "r497" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement does not require Recovery" } } }, "auth_ref": [ "r458", "r469", "r479", "r504" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets", "http://appyea.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r46", "r61", "r292", "r308", "r309", "r313", "r333", "r421" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r87", "r110", "r111", "r112", "r114", "r119", "r121", "r123", "r147", "r148", "r149", "r215", "r216", "r218", "r219", "r220", "r222", "r223", "r224", "r232", "r234", "r235", "r237", "r238", "r260", "r262", "r305", "r307", "r319", "r571" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Sales", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r75", "r76", "r132", "r135", "r136", "r139", "r141", "r142", "r143", "r144", "r171", "r172", "r282" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://appyea.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r354", "r394", "r397" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r513" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r513" ] }, "us-gaap_SalariesWagesAndOfficersCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalariesWagesAndOfficersCompensation", "crdr": "debit", "presentation": [ "http://appyea.com/role/ScheduleOfTransactionWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Salaries and related cost (including stock-based compensation in the amount of $116,000 and $721,000, respectively)", "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold." } } }, "auth_ref": [] }, "APYP_ScheduleOfBalancesWithRelatedPartiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://appyea.com/20240331", "localname": "ScheduleOfBalancesWithRelatedPartiesTableTextBlock", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BALANCE WITH RELATED PARTIES", "documentation": "Schedule of Balances with Related Parties [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS", "documentation": "Tabular disclosure of the change in common stock outstanding." } } }, "auth_ref": [] }, "APYP_ScheduleOfConvertibleLoansAmortizedCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://appyea.com/20240331", "localname": "ScheduleOfConvertibleLoansAmortizedCostsTableTextBlock", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST", "documentation": "Schedule of Convertibe Loans Amortized Costs [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan [Table]", "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r5", "r21", "r22", "r23", "r24" ] }, "APYP_ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://appyea.com/20240331", "localname": "ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock", "presentation": [ "http://appyea.com/role/ConvertibleLoansAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED", "documentation": "Schedule of Fair Values of Warrants and Convertible Loan Assumption Used [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r33", "r34", "r356", "r357", "r360" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF TRANSACTION WITH RELATED PARTIES", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://appyea.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF NUMBER OF OPTIONS", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r7", "r8", "r66" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r435" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r439" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r438" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r444" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Sales and marketing", "label": "Selling and Marketing Expense", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://appyea.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://appyea.com/role/StatementsOfCashFlows", "http://appyea.com/role/StockBasedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Option vesting description", "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Expected dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r206" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r207" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Expected average (Monte Carlo) volatility", "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement." } } }, "auth_ref": [ "r205" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r411" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of options, Exercisable balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r188" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, Exercisable balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r188" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options, Granted", "verboseLabel": "Number of shares issued", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r190" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of options, Outstanding balance", "periodEndLabel": "Number of options, Outstanding balance", "label": "Options outstanding", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r186", "r187" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, Outstanding balance", "periodEndLabel": "Weighted average exercise price, Outstanding balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r186", "r187" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r191" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r190" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharePrice", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Expected term (in years)", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r204" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "APYP_SharesToBeIssuedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "SharesToBeIssuedDuringPeriodValue", "crdr": "credit", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Shares to be issued" } } }, "auth_ref": [] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermBorrowings", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Short-term loans from related party", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r35", "r68", "r421", "r564" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://appyea.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r59", "r106" ] }, "APYP_SignificantEventsDuringThePeriodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://appyea.com/20240331", "localname": "SignificantEventsDuringThePeriodTextBlock", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriod" ], "lang": { "en-us": { "role": { "label": "SIGNIFICANT EVENTS DURING THE PERIOD" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r442" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative", "http://appyea.com/role/StatementsOfChangesInDeficiency", "http://appyea.com/role/SubsequentEventsDetailsNarrative", "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r6", "r44", "r47", "r48", "r87", "r99", "r100", "r101", "r110", "r111", "r112", "r114", "r119", "r121", "r123", "r133", "r147", "r148", "r149", "r170", "r215", "r216", "r218", "r219", "r220", "r222", "r223", "r224", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r251", "r252", "r253", "r254", "r255", "r256", "r260", "r262", "r264", "r300", "r305", "r306", "r307", "r319", "r375" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative", "http://appyea.com/role/StatementsOfChangesInDeficiency", "http://appyea.com/role/StockBasedCompensationDetailsNarrative", "http://appyea.com/role/StockBasedCompensationTables", "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r110", "r111", "r112", "r133", "r262", "r282", "r311", "r320", "r325", "r326", "r327", "r328", "r329", "r330", "r332", "r335", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r346", "r347", "r348", "r349", "r350", "r352", "r354", "r355", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r375", "r426" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative", "http://appyea.com/role/StatementsOfChangesInDeficiency", "http://appyea.com/role/StockBasedCompensationDetailsNarrative", "http://appyea.com/role/StockBasedCompensationTables", "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r110", "r111", "r112", "r133", "r145", "r262", "r282", "r311", "r320", "r325", "r326", "r327", "r328", "r329", "r330", "r332", "r335", "r336", "r337", "r338", "r339", "r341", "r342", "r343", "r344", "r346", "r347", "r348", "r349", "r350", "r352", "r354", "r355", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r375", "r426" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r453", "r464", "r474", "r499" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Share issuance upon conversion of Convertible notes, shares", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r6", "r19", "r44", "r47", "r61", "r167" ] }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option granted", "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan." } } }, "auth_ref": [ "r6", "r29", "r43", "r44", "r61" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Issuance of Shares, shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r6", "r43", "r44", "r61", "r312", "r375", "r389" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Options exercise, shares", "negatedLabel": "Number of options, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r6", "r43", "r44", "r61", "r191" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Share issuance upon conversion of Convertible notes.", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r6", "r44", "r47", "r48", "r61" ] }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "crdr": "credit", "presentation": [ "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option granted, value", "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r6", "r29", "r43", "r44", "r61" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Issuance of Shares", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r6", "r43", "r44", "r61", "r319", "r375", "r389", "r432" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Options exercise", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r6", "r44", "r47", "r48", "r61" ] }, "us-gaap_StockOptionPlanExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockOptionPlanExpense", "crdr": "debit", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issuance total expense", "documentation": "Amount of noncash expense for option under share-based payment arrangement." } } }, "auth_ref": [ "r3" ] }, "APYP_StockPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "StockPayables", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stock payables", "documentation": "Stock Payables." } } }, "auth_ref": [] }, "APYP_StockPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "StockPayablesMember", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Stock Payables [Member]", "documentation": "Stock Payables [Member]" } } }, "auth_ref": [] }, "APYP_StockToBeIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "StockToBeIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Shares to be issued to service providers", "documentation": "Shares to be issued to service providers." } } }, "auth_ref": [] }, "APYP_StockToBeIssuedDuringPeriodValueIssuedToInvestors": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "StockToBeIssuedDuringPeriodValueIssuedToInvestors", "crdr": "credit", "presentation": [ "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "label": "Shares to be issued to investors", "documentation": "Shares to be issued to investors." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets", "http://appyea.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "totalLabel": "Total AppYea Inc. stockholders\u2019 deficiency", "label": "Stockholders' deficiency", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r44", "r47", "r48", "r60", "r334", "r351", "r376", "r377", "r421", "r433", "r524", "r536", "r551", "r571" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "AppYea Inc. Stockholders\u2019 Deficiency:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://appyea.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://appyea.com/role/BalanceSheets", "http://appyea.com/role/StatementsOfChangesInDeficiency" ], "lang": { "en-us": { "role": { "totalLabel": "Total Deficiency", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r30", "r31", "r32", "r87", "r88", "r100", "r110", "r111", "r112", "r114", "r119", "r121", "r147", "r148", "r149", "r170", "r215", "r216", "r218", "r219", "r220", "r222", "r223", "r224", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r251", "r252", "r256", "r261", "r264", "r306", "r307", "r317", "r334", "r351", "r376", "r377", "r390", "r432", "r524", "r536", "r551", "r571" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://appyea.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "DEFICIENCY" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r257", "r274" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r257", "r274" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r257", "r274" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r257", "r274" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r257", "r274" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://appyea.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r273", "r275" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List, Table" } } }, "auth_ref": [ "r493" ] }, "APYP_TanoomaLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "TanoomaLtdMember", "presentation": [ "http://appyea.com/role/RelatedPartyBalancesAndTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tanooma Ltd [Member]", "documentation": "Tanooma Ltd [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualAxis", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative", "http://appyea.com/role/StockBasedCompensationDetailsNarrative", "http://appyea.com/role/StockBasedCompensationTables", "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]" } } }, "auth_ref": [ "r534", "r553" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://appyea.com/role/ScheduleOfNumberOfOptionsDetails", "http://appyea.com/role/SignificantEventsDuringPeriodDetailsNarrative", "http://appyea.com/role/StockBasedCompensationDetailsNarrative", "http://appyea.com/role/StockBasedCompensationTables", "http://appyea.com/role/SubsequentEventsDetailsNarrative" ], "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r485" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r492" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "APYP_TransitionFromConvertibleLoansMeasuredAtFairValueToMeasurementAtAmortizedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://appyea.com/20240331", "localname": "TransitionFromConvertibleLoansMeasuredAtFairValueToMeasurementAtAmortizedCost", "crdr": "credit", "presentation": [ "http://appyea.com/role/ScheduleOfConvertibleLoansAmortizedCostDetails" ], "lang": { "en-us": { "role": { "label": "Transition from convertible loans measured at fair value to measurement at amortized cost", "documentation": "Transition from convertible loans measured at fair value to measurement at amortized cost." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r515" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r516" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Expiration Date" } } }, "auth_ref": [ "r516" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "verboseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r514" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r514" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r515" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r511" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://appyea.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates in Preparation of Financial Statements", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r16", "r17", "r18", "r81", "r82", "r83", "r84" ] }, "APYP_WarrantOneMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "WarrantOneMember", "presentation": [ "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant One [Member]", "documentation": "Warrant One [Member]" } } }, "auth_ref": [] }, "APYP_WarrantThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "WarrantThreeMember", "presentation": [ "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant Three [Member]", "documentation": "Warrant Three [Member]" } } }, "auth_ref": [] }, "APYP_WarrantTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://appyea.com/20240331", "localname": "WarrantTwoMember", "presentation": [ "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant Two [Member]", "documentation": "Warrant Two [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "presentation": [ "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding and Exercisable, value", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [ "r545", "r546", "r547" ] }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingMeasurementInput", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails" ], "lang": { "en-us": { "role": { "label": "Warrants rights outstanding measurement input", "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur." } } }, "auth_ref": [ "r545", "r546", "r547" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://appyea.com/role/ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedDetails", "http://appyea.com/role/SummarizesRelatingToOutstandingAndExercisableWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Expected term", "verboseLabel": "Weighted Average Remaining Contractual life (in years)", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r545", "r546", "r547" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average number of Common Shares Outstanding diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r125", "r130" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://appyea.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average number of Common Shares Outstanding basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r124", "r130" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://appyea.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r520" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "25", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480637/718-40-25-10" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/710/tableOfContent" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "712", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/712/tableOfContent" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/715/tableOfContent" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.FF.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476188/405-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r395": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r398": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r401": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r402": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r405": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r406": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r407": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r410": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r411": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r413": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r414": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r415": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r416": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r417": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r418": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r419": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r420": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r421": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r422": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r423": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r425": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r430": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r431": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r432": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r433": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r434": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r435": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r436": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r438": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r440": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r441": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r442": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r443": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r444": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r445": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r446": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r447": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r448": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r449": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r450": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r451": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r452": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r453": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r454": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r455": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r456": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r457": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r458": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r459": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r460": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r461": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r462": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r463": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r464": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r465": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r466": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r467": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r468": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r469": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r470": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r471": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r472": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r473": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r474": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r475": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r476": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r477": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r478": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r479": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r480": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r482": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r483": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r484": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r485": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r486": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r487": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r488": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r489": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r490": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r491": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r492": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r493": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r494": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r495": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r496": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r497": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r498": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r499": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r500": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r501": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r502": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r503": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r504": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r505": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r506": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r507": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r508": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r509": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r510": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r511": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r512": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r513": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r514": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r515": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r516": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r517": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r518": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r519": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r520": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r521": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r522": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r523": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r524": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r525": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r526": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r527": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r528": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r529": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r530": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r531": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r532": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r533": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r534": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r535": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r536": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r537": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r538": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r539": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r540": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r541": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r542": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r543": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r544": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r545": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r546": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r547": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r549": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r550": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r551": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r552": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r553": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r554": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r555": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r556": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 54 0001493152-24-020652-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-020652-xbrl.zip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�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end XML 56 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001568969 2024-01-01 2024-03-31 0001568969 2024-05-20 0001568969 2024-03-31 0001568969 2023-12-31 0001568969 us-gaap:RelatedPartyMember 2024-03-31 0001568969 us-gaap:RelatedPartyMember 2023-12-31 0001568969 2023-01-01 2023-03-31 0001568969 us-gaap:PreferredStockMember 2023-12-31 0001568969 us-gaap:CommonStockMember 2023-12-31 0001568969 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001568969 APYP:StockPayablesMember 2023-12-31 0001568969 us-gaap:RetainedEarningsMember 2023-12-31 0001568969 us-gaap:ParentMember 2023-12-31 0001568969 us-gaap:NoncontrollingInterestMember 2023-12-31 0001568969 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001568969 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001568969 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001568969 APYP:StockPayablesMember 2024-01-01 2024-03-31 0001568969 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001568969 us-gaap:ParentMember 2024-01-01 2024-03-31 0001568969 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001568969 us-gaap:PreferredStockMember 2024-03-31 0001568969 us-gaap:CommonStockMember 2024-03-31 0001568969 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001568969 APYP:StockPayablesMember 2024-03-31 0001568969 us-gaap:RetainedEarningsMember 2024-03-31 0001568969 us-gaap:ParentMember 2024-03-31 0001568969 us-gaap:NoncontrollingInterestMember 2024-03-31 0001568969 us-gaap:PreferredStockMember 2022-12-31 0001568969 us-gaap:CommonStockMember 2022-12-31 0001568969 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001568969 APYP:StockPayablesMember 2022-12-31 0001568969 us-gaap:RetainedEarningsMember 2022-12-31 0001568969 us-gaap:ParentMember 2022-12-31 0001568969 us-gaap:NoncontrollingInterestMember 2022-12-31 0001568969 2022-12-31 0001568969 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001568969 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001568969 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001568969 APYP:StockPayablesMember 2023-01-01 2023-03-31 0001568969 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001568969 us-gaap:ParentMember 2023-01-01 2023-03-31 0001568969 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001568969 us-gaap:PreferredStockMember 2023-03-31 0001568969 us-gaap:CommonStockMember 2023-03-31 0001568969 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001568969 APYP:StockPayablesMember 2023-03-31 0001568969 us-gaap:RetainedEarningsMember 2023-03-31 0001568969 us-gaap:ParentMember 2023-03-31 0001568969 us-gaap:NoncontrollingInterestMember 2023-03-31 0001568969 2023-03-31 0001568969 APYP:NexenseTechnologiesLTDMember 2021-12-31 0001568969 APYP:NexenseTechnologiesLTDMember 2024-01-01 2024-03-31 0001568969 us-gaap:NoncontrollingInterestMember APYP:TanoomaLtdMember 2020-12-31 0001568969 us-gaap:NoncontrollingInterestMember APYP:TanoomaLtdMember 2024-03-31 0001568969 APYP:OldCLAMember 2024-01-01 2024-03-31 0001568969 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001568969 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001568969 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001568969 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001568969 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001568969 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001568969 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001568969 us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0001568969 2023-01-01 2023-12-31 0001568969 APYP:OldCLAMember 2023-01-01 2023-12-31 0001568969 APYP:OldCLAMember 2024-03-31 0001568969 APYP:OldCLAMember 2023-12-31 0001568969 us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001568969 us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001568969 us-gaap:MeasurementInputExpectedDividendRateMember 2024-03-31 0001568969 us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001568969 us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001568969 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001568969 APYP:MeasurementInputCommonMarketValueMember 2024-03-31 0001568969 APYP:MeasurementInputCommonMarketValueMember 2023-12-31 0001568969 APYP:WarrantOneMember 2023-12-31 0001568969 APYP:WarrantTwoMember 2023-12-31 0001568969 APYP:WarrantThreeMember 2023-12-31 0001568969 APYP:WarrantOneMember 2024-03-31 0001568969 APYP:WarrantTwoMember 2024-03-31 0001568969 APYP:WarrantThreeMember 2024-03-31 0001568969 APYP:ConsultantsAndEmployeesMember 2024-01-01 2024-03-31 0001568969 APYP:ConsultantsAndEmployeesMember 2023-12-31 0001568969 APYP:ConsultantsAndEmployeesMember 2024-03-31 0001568969 APYP:ChiefFinancialOfficerAndAdvisorMember 2024-01-01 2024-03-31 0001568969 APYP:ChiefFinancialOfficerAndAdvisorMember 2023-01-01 2023-03-31 0001568969 APYP:ConsultantMember 2024-01-01 2024-01-01 0001568969 APYP:ConsultantMember 2024-01-01 0001568969 APYP:ConsultantOneMember 2024-01-01 2024-01-01 0001568969 APYP:ConsultantOneMember 2024-01-01 0001568969 APYP:ConsultantTwoMember 2024-01-01 2024-01-01 0001568969 APYP:ConsultantTwoMember 2024-01-01 0001568969 APYP:BorisMolchadskyMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-05-14 0001568969 APYP:AsafPoratMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-05-14 0001568969 APYP:AdiShemerMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-05-14 0001568969 APYP:BorisMolchadskyMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-05-14 2024-05-14 0001568969 APYP:AsafPoratMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2024-05-14 2024-05-14 0001568969 us-gaap:SubsequentEventMember 2024-05-14 2024-05-14 0001568969 APYP:OfficerAndDirectorMember us-gaap:SubsequentEventMember 2024-04-01 0001568969 APYP:AdiShemerMember us-gaap:SubsequentEventMember 2024-07-01 0001568969 srt:MinimumMember APYP:AdiShemerMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-01 iso4217:USD shares iso4217:USD shares pure APYP:Integer iso4217:ILS false Q1 --12-31 0001568969 10-Q true 2024-03-31 2024 false 000-55403 APPYEA, Inc. NV 46-1496846 16 Natan Alterman St Gan Yavne IL (800) 674-3561 Yes Yes Non-accelerated Filer true false false 451113064 373000 222000 1000 30000 42000 14000 14000 418000 278000 2000 3000 238000 193000 240000 196000 658000 474000 24000 51000 679000 694000 79000 79000 811000 796000 2160000 1203000 72000 204000 3825000 3027000 3825000 3027000 0.0001 0.0001 0.0001 0.0001 41000 31000 657000 559000 3719000 3197000 -7570000 -6326000 -3153000 -2539000 -14000 -14000 -3167000 -2553000 658000 474000 13000 3000 10000 60000 9000 54000 294000 427000 -398000 -436000 -824000 166000 -22000 -19000 -1244000 -289000 -1244000 -289000 -1244000 -289000 -0.003 -0.003 -0.001 -0.001 380266957 380266957 225248108 225248108 258745 328836657 31000 3197000 559000 -6326000 -2539000 -14000 -2553000 147000 147000 147000 -1244000 -1244000 -1244000 25000 25000 25000 60143100 6000 379000 -2000 383000 383000 75000 75000 75000 500000 -28147 42217500 4000 -4000 230598 431697257 41000 3719000 657000 -7570000 -3153000 -14000 -3167000 300000 220930798 21000 1912000 27000 -4509000 -2549000 -14000 -2563000 300000 220930798 21000 1912000 27000 -4509000 -2549000 -14000 -2563000 279000 279000 279000 -289000 -289000 -289000 1000 1000 1000 8634616 1000 160000 161000 161000 300000 229565414 22000 2351000 28000 -4798000 -2397000 -14000 -2411000 300000 229565414 22000 2351000 28000 -4798000 -2397000 -14000 -2411000 -1244000 -289000 6000 6000 172000 279000 -824000 147000 14000 -11000 -1000 -24000 74000 -16000 -21000 -257000 -97000 50000 -50000 381000 141000 75000 456000 141000 3000 -4000 152000 40000 222000 60000 373000 100000 NOTE 1 - GENERAL AppYea, Inc. (“AppYea”, “the Company”, “we” or “us”) was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and no operating history. On November 1, 2021 the Company was redomiciled in the State of Nevada. The Company’s common stock is traded on the OTC Markets, OTCQB tier, under the symbol “APYP”. SleepX LTD is a company formed under the laws of the State of Israel and a wholly owned subsidiary of the Company (“SleepX”). SleepX is a research and development company that has developed a proprietary product for monitoring and treating sleep apnea and snoring. The technology is protected by several international patents and the Company started serial production in 2023. Subject to raising working capital, of which no assurance can be provided, the Company intends to focus on further development and commercialization of its products. SleepX has incorporated, together with an unrelated third party, a privately held company under the laws of the State of Israel named Ta-nooma Ltd. (“Ta-nooma”). Ta-nooma has developed sleeping monitoring technology for which patent applications were filed and has no revenue from operations. Since its incorporation and as of the financial statements date, Sleepx holds 66.7% of the voting interest of Ta-nooma. Strategic Development The company flagship product is AppySleep – A Biofeedback snoring treatment wristband, combined with the AppySleep App (“AppySleep”). The AppySleep product is currently in serial manufacturing and commercial stage. Financial position The financial statements are presented on a going-concern basis. To date, the Company has not generated any significant revenues, suffered recurring losses from operations, incurred negative cash flows from operating activities, and is dependent upon external sources for financing its operations. As of March 31, 2024, the Company had an accumulated deficit of $7,570,000 and a stockholders’ deficiency of $3,153,000. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The Company intends to continue to finance its operating activities by raising capital. There are no assurances that the Company will be successful in obtaining an adequate level of financing needed for its long-term research and development activities on commercially reasonable terms or at all. If the Company will not have sufficient liquidity resources, the Company may not be able to continue the development of its product candidates or may be required to implement cost reduction measures and may be required to delay part of its development programs. The financial statements do not include any adjustments for the values of assets and liabilities and their classification that may be necessary in the event that the Company is no longer able to continue its operations as a “going concern”. APPYEA INC. NOTES TO THE FINANCIAL STATEMENTS -7570000 -3153000 NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES The interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The interim financial statements do not include a full disclosure as required in annual financial statements and should be read with the annual financial statements of the Company as of December 31, 2023 from which the accompanying condensed consolidated balance sheet dated December 31, 2023, was derived. The accounting policies implemented in the interim financial statements are consistent with the accounting policies implemented in the annual financial statements as of December 31, 2023, except of the following accounting pronouncement adopted by the Company. Recently Issued Accounting Pronouncements Effective January 1, 2024, the Company adopted ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), which is intended to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. For convertible instruments, ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stocks, and enhances information transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share guidance on the basis of feedback from financial statement users. The adoption of this new accounting guidance did not have an effect on the consolidated financial statements. Effective January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326),” referred to herein as ASU 2016-13, which significantly changes how entities will account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaced the existing incurred loss model with an expected credit loss model that requires entities to estimate an expected lifetime credit loss on most financial assets and certain other instruments. Under ASU 2016-13 credit impairment is recognized as an allowance for credit losses, rather than as a direct write-down of the amortized cost basis of a financial asset. The impairment allowance is a valuation account deducted from the amortized cost basis of financial assets to present the net amount expected to be collected on the financial asset. Once the new pronouncement is adopted by the Company, the allowance for credit losses must be adjusted for management’s current estimate at each reporting date. The new guidance provides no threshold for recognition of impairment allowance. Therefore, entities must also measure expected credit losses on assets that have a low risk of loss. For instance, trade receivables that are either current or not yet due may not require an allowance reserve under current generally accepted accounting principles, but under the new standard, the Company will have to estimate an allowance for expected credit losses on trade receivables under ASU 2016-13. The Company determined the adoption of this new accounting guidance and the effect on its financial statements throughout the period until implementation, and have no impact on the financial statements. In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s financial statements. Use of Estimates in Preparation of Financial Statements The preparation of consolidated financial statements in conformity with U.S. GAAP accounting principles requires management to make estimates and assumptions. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Revenue Recognition The Company recognizes revenue under ASC 606, Revenue Recognition at the amount to which it expects to be entitled when control of the products or services is transferred to its customers. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. Our contracts are typically governed by a customer purchase order. The contract generally specifies the delivery of what constitutes a single performance obligation. If an arrangement involves multiple performance obligations, the items are analyzed to determine the separate units of accounting, whether the items have value on a standalone basis and whether there is objective and reliable evidence of their standalone selling price. The total contract transaction price is allocated to the identified performance obligations based upon the relative standalone selling prices of the performance obligations. The standalone selling price is based on an observable price for services sold to other comparable customers. As discussed in more detail below, revenue is recognized when a customer obtains control of promised goods or services under the terms of a contract and is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. We do not have any material extended payment terms, as payment is due at or shortly after the time of the sale. Sales, value-added and other taxes collected concurrently with revenue producing activities are excluded from revenue. A contract liability is recognized as deferred revenue when we invoice customers, or receive customer cash payments, in advance of satisfying the related performance obligation(s) under the terms of a contract. Deferred revenue is recognized as revenue when we have satisfied the related performance obligation. We have one main revenue stream: wristband sales, with the AppySleep App. For this revenue stream, our performance obligations are satisfied at a point in time, and therefore, revenue is recognized at point in time when a customer takes control of the good or asset created by the service. Factors that may indicate transfer of control are when we have the right to receive payment for the good or service, when the legal title of the asset has been transferred, physical possession of the asset has been transferred, the customer obtains the significant risks and rewards of ownership of the asset, and the customer accepts the asset. For customers, control is transferred upon delivery. We leverage drop-ship shipments with our partners and suppliers to deliver wristbands to our customers without having to physically hold the inventory at our warehouses, thereby increasing efficiency and reducing costs. We recognize revenue for drop-ship arrangements on a gross basis as the principal in the transaction when the product is received by the customer because we control the product prior to transfer to the customer. We also assume primary responsibility for the fulfillment in the arrangement, we assume inventory risk if something were to happen to the hardware during shipping, we set the price of the product charged to the customer. The Company intend to recognize records reductions to Products net sales related to future product returns, price protection and other customer incentive programs based on the Company’s expectations and historical experience. APPYEA INC. NOTES TO THE FINANCIAL STATEMENTS Recently Issued Accounting Pronouncements Effective January 1, 2024, the Company adopted ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), which is intended to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. For convertible instruments, ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stocks, and enhances information transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share guidance on the basis of feedback from financial statement users. The adoption of this new accounting guidance did not have an effect on the consolidated financial statements. Effective January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326),” referred to herein as ASU 2016-13, which significantly changes how entities will account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaced the existing incurred loss model with an expected credit loss model that requires entities to estimate an expected lifetime credit loss on most financial assets and certain other instruments. Under ASU 2016-13 credit impairment is recognized as an allowance for credit losses, rather than as a direct write-down of the amortized cost basis of a financial asset. The impairment allowance is a valuation account deducted from the amortized cost basis of financial assets to present the net amount expected to be collected on the financial asset. Once the new pronouncement is adopted by the Company, the allowance for credit losses must be adjusted for management’s current estimate at each reporting date. The new guidance provides no threshold for recognition of impairment allowance. Therefore, entities must also measure expected credit losses on assets that have a low risk of loss. For instance, trade receivables that are either current or not yet due may not require an allowance reserve under current generally accepted accounting principles, but under the new standard, the Company will have to estimate an allowance for expected credit losses on trade receivables under ASU 2016-13. The Company determined the adoption of this new accounting guidance and the effect on its financial statements throughout the period until implementation, and have no impact on the financial statements. In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024. The adoption of this pronouncement is not expected to have a material impact on the Company’s financial statements. Use of Estimates in Preparation of Financial Statements The preparation of consolidated financial statements in conformity with U.S. GAAP accounting principles requires management to make estimates and assumptions. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Revenue Recognition The Company recognizes revenue under ASC 606, Revenue Recognition at the amount to which it expects to be entitled when control of the products or services is transferred to its customers. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, a performance obligation is satisfied. Our contracts are typically governed by a customer purchase order. The contract generally specifies the delivery of what constitutes a single performance obligation. If an arrangement involves multiple performance obligations, the items are analyzed to determine the separate units of accounting, whether the items have value on a standalone basis and whether there is objective and reliable evidence of their standalone selling price. The total contract transaction price is allocated to the identified performance obligations based upon the relative standalone selling prices of the performance obligations. The standalone selling price is based on an observable price for services sold to other comparable customers. As discussed in more detail below, revenue is recognized when a customer obtains control of promised goods or services under the terms of a contract and is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. We do not have any material extended payment terms, as payment is due at or shortly after the time of the sale. Sales, value-added and other taxes collected concurrently with revenue producing activities are excluded from revenue. A contract liability is recognized as deferred revenue when we invoice customers, or receive customer cash payments, in advance of satisfying the related performance obligation(s) under the terms of a contract. Deferred revenue is recognized as revenue when we have satisfied the related performance obligation. We have one main revenue stream: wristband sales, with the AppySleep App. For this revenue stream, our performance obligations are satisfied at a point in time, and therefore, revenue is recognized at point in time when a customer takes control of the good or asset created by the service. Factors that may indicate transfer of control are when we have the right to receive payment for the good or service, when the legal title of the asset has been transferred, physical possession of the asset has been transferred, the customer obtains the significant risks and rewards of ownership of the asset, and the customer accepts the asset. For customers, control is transferred upon delivery. We leverage drop-ship shipments with our partners and suppliers to deliver wristbands to our customers without having to physically hold the inventory at our warehouses, thereby increasing efficiency and reducing costs. We recognize revenue for drop-ship arrangements on a gross basis as the principal in the transaction when the product is received by the customer because we control the product prior to transfer to the customer. We also assume primary responsibility for the fulfillment in the arrangement, we assume inventory risk if something were to happen to the hardware during shipping, we set the price of the product charged to the customer. The Company intend to recognize records reductions to Products net sales related to future product returns, price protection and other customer incentive programs based on the Company’s expectations and historical experience. NOTE 3 - RELATED PARTY BALANCES AND TRANSACTIONS <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.75in"> </td> <td style="text-align: justify; width: 0.25in">A. </td> <td style="text-align: justify">Short-term loans from related parties</td></tr> </table> During 2021, SleepX borrowed from Nexense Technologies USA. Inc., a Delaware corporation which is majority owned by Boris Molchadsky, the Company’s Chairman. an aggregate amount of $47,623. According to the agreement, the loan shall be repaid in the event that the Company’s profits are sufficient to repay the aggregate loan amount and upon such terms and in such installments as shall be determined by the Board. The loan shall bear interest at an annual rate equal to the minimum rate approved by applicable law in Israel (<span id="xdx_907_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20240101__20240331__us-gaap--RelatedPartyTransactionAxis__custom--NexenseTechnologiesLTDMember_zOpMJjrjmfEf" title="Related-party transaction rate">5.18% in 2024). During 2020, the minority shareholder of Ta-nooma advanced a loan to Ta-nooma in the amount of NIS <span id="xdx_90D_eus-gaap--OtherLiabilities_iI_uNIS_c20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__dei--LegalEntityAxis__custom--TanoomaLtdMember_z12K5VNS2yLd" title="Due to related parties current and noncurrent">115,725. The loan does not carry any interest expense and the repayment terms have yet to be determined. As of March 31, 2024, the loan balance amounted to NIS <span id="xdx_907_eus-gaap--OtherLiabilities_iI_pp0p0_uNIS_c20240331__dei--LegalEntityAxis__custom--TanoomaLtdMember__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zVoXB3pjJQS3" title="Due to related parties current and noncurrent">115,725 ($<span id="xdx_907_eus-gaap--OtherLiabilities_iI_pp0p0_c20240331__dei--LegalEntityAxis__custom--TanoomaLtdMember__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z4UsEZmC6ro3" title="Due to related parties current and noncurrent">31,906). <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.75in"> </td> <td style="text-align: justify; width: 0.25in">B. </td> <td style="text-align: justify">Balances with related parties</td></tr> </table> SCHEDULE OF BALANCE WITH RELATED PARTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20240331_zAcETXWh0WIb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zkNzXbCxJL0a" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">In U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesAbstract_iB_zqsij4b7Par8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_zxlEAUbZF0r6" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Employees and payroll accruals</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">267</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">498</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NotesPayableCurrent_iI_pn3n3_zp4H06rAJmK8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Related party payables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">129</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherNotesPayableCurrent_iI_pn3n3_zlnJNZG6Hty3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short term loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79</td><td style="text-align: left"> </td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.75in"> </td> <td style="text-align: justify; width: 0.25in">C. </td> <td style="text-align: justify">Transactions with related parties</td></tr> </table> SCHEDULE OF TRANSACTION WITH RELATED PARTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20240101__20240331_z8N343XkMZx7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230331_z52Cn7Z4Mjq8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the three months ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">In U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SalariesWagesAndOfficersCompensation_pn3n3_zfAydHYgBAWc" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Salaries and related cost (including stock-based compensation in the amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRSQU5TQUNUSU9OIFdJVEggUkVMQVRFRCBQQVJUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20240101__20240331_zoqEKmGmNgYl" title="Shared based compensation">116,000 and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRSQU5TQUNUSU9OIFdJVEggUkVMQVRFRCBQQVJUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20230101__20230331_zOrLjck0chx8" title="Shared based compensation">721,000, respectively)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">190</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,067</td><td style="width: 1%; text-align: left"> </td></tr> </table> Both the Chairman and the chief financial officer are directors in the Company and do not receive compensation for their directorship roles. Company’s Bylaws provide that a director or officer shall be indemnified and held harmless by the Corporation, to the fullest extent permitted by the laws of the State of Nevada. APPYEA INC. NOTES TO THE FINANCIAL STATEMENTS 47623 0.0518 115725 115725 31906 SCHEDULE OF BALANCE WITH RELATED PARTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20240331_zAcETXWh0WIb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20231231_zkNzXbCxJL0a" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">In U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesAbstract_iB_zqsij4b7Par8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pn3n3_zxlEAUbZF0r6" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Employees and payroll accruals</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">267</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">498</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NotesPayableCurrent_iI_pn3n3_zp4H06rAJmK8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Related party payables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">129</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherNotesPayableCurrent_iI_pn3n3_zlnJNZG6Hty3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short term loans</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79</td><td style="text-align: left"> </td></tr> </table> 267000 498000 208000 129000 79000 79000 SCHEDULE OF TRANSACTION WITH RELATED PARTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20240101__20240331_z8N343XkMZx7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230331_z52Cn7Z4Mjq8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the three months ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">In U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SalariesWagesAndOfficersCompensation_pn3n3_zfAydHYgBAWc" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Salaries and related cost (including stock-based compensation in the amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRSQU5TQUNUSU9OIFdJVEggUkVMQVRFRCBQQVJUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20240101__20240331_zoqEKmGmNgYl" title="Shared based compensation">116,000 and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFRSQU5TQUNUSU9OIFdJVEggUkVMQVRFRCBQQVJUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20230101__20230331_zOrLjck0chx8" title="Shared based compensation">721,000, respectively)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">190</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,067</td><td style="width: 1%; text-align: left"> </td></tr> </table> 116000 721000 190000 1067000 NOTE 4 - CONVERTIBLE LOANS AND WARRANTS The following table summarizes fair value measurements by level as of March 31, 2024 and December 31, 2023 measured at fair value on a recurring basis: <p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_z5JeAUfKj4pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">SCHEDULE OF FAIR VALUE RECURRING BASIS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center">In U.S. dollars</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">None</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z3YrKFhpTcz2" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zwaAAx3DF4yd" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7trzC2JRB62" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ze99KISj0yy7" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; text-align: justify">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify">Convertible Loans At fair value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zcqXDSXaDTNa" style="width: 12%; text-align: right" title="Convertible Loans at fair value">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zscUsVDXmcb1" style="width: 12%; text-align: right" title="Convertible Loans at fair value">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zoqirqVF2wob" style="width: 12%; text-align: right" title="Convertible Loans at fair value">1,203</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7nCEdkkUVHl" style="width: 12%; text-align: right" title="Convertible Loans at fair value">1,203</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Financial liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk51fEkSyo45" style="text-align: right" title="Financial liability">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zYCOYcMdzeuf" style="text-align: right" title="Financial liability">204</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zv1I4MJA1gvj" style="text-align: right" title="Financial liability">204</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">March 31, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center">In U.S. dollars</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">None</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zt0ayPi0zovb" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIrDieP7rVp" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztthXSfbjVmc" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20240331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIHafEP6pW" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; text-align: justify">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify">Convertible Loans At fair value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxKhvWZqPXj8" style="width: 12%; text-align: right" title="Convertible Loans at fair value">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zw42LC5svKTg" style="width: 12%; text-align: right" title="Convertible Loans at fair value">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z1QuaVUsoDgi" style="width: 12%; text-align: right" title="Convertible Loans at fair value">2,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zau1XPMYQmU2" style="width: 12%; text-align: right" title="Convertible Loans at fair value">2,160</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Financial liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztuJQD57wGF4" style="text-align: right" title="Financial liability">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zcgdpuIPuYu2" style="text-align: right" title="Financial liability">72</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2mMyfCpy1Oi" style="text-align: right" title="Financial liability">72</td><td style="text-align: left"> </td></tr> </table> APPYEA INC. NOTES TO THE FINANCIAL STATEMENTS <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">NOTE 4</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.25in">- </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">CONVERTIBLE LOANS AND WARRANTS (cont.)</td></tr> </table> The Convertible Loans changes consist of the following as of March 31, 2024 and December 31, 2023: SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20240101__20240331_zE2ROWPgsrLi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20230101__20231231_zK3Umv9W4dD7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible Loans at Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">$000</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleDebt_iS_pn3n3_zKuE8cUSOyLl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Opening Balance, (including short term loans from related party which is also convertible)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">1,203</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">2,257</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium_pn3n3_zYeGQ59OUxV9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additional convertible loans (a)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ConversionOfConvertibleLoan_pn3n3_zg3xfqLem3Nl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Conversion of convertible loan (b)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(243</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--DecreaseOfNotesPurchased_pn3n3_ztlYMdgmacwd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Decrease of notes purchased</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(530</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--ChangeInFairValueOfConvertibleLoansLiabilityThroughProfitOrLoss_iN_pn3n3_di_z9tWyvdzbZvi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible loans liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">957</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(434</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--ConvertibleDebt_iE_pn3n3_zxHPZE3XvQ97" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,160</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,203</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(a)</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the quarter ended March 31, 2024, and the year ended December 31, 2023, the Company raised a principal amount of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_dxL_c20240331_zyac4uYBSbZ2" title="Principal amount::XDX::-">nill and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20231231_za2VkIjVPIj" title="Principal amount">152,750, respectively.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(b)</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the quarter ended March 31, 2024, and the year ended December 31, 2023 a total amount of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_dxL_c20240101__20240331_zM492x3KyGNb" title="Converted amount::XDX::-">nill and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230101__20231231_zq1jrRHNYKt4" title="Converted amount">242,538 (which were converted into <span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20230101__20231231_zMRKIfvAQMh4" title="Number of shares converted">8,634,616 shares of common stock), respectively.</td></tr></table> <p id="xdx_894_ecustom--ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zYyqMkddjkM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The estimated fair values of the Convertible loans were measured according to the Monte Carlo Model using the following assumptions: SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_493_20240101__20240331_z5vsV9n7sbe5" style="text-align: center">As of </td><td> </td><td> </td> <td colspan="2" id="xdx_492_20230101__20231231_zbvn82XMDoA7" style="text-align: center">As of </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Expected term (in years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zrtPTPS7Y2Q4" title="Expected term (in years)">0.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zvVxsPSQuLTc" title="Expected term (in years)">0.5</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zCgeAY9DSmjf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected average (Monte Carlo) volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">213</td><td style="text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zLiZ5SGoOdXf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zfUYGMmJBLTd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.46</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.26</td><td style="text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--PercentageOfWeightedAverageCostInventory_iE_pid_dp_uPure_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zfnuLJ2MuNtl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">WACC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27</td><td style="text-align: left">%</td></tr> </table> APPYEA INC. NOTES TO THE FINANCIAL STATEMENTS <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">NOTE 4</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.25in">- </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">CONVERTIBLE LOANS AND WARRANTS (cont.)</td></tr> </table> The following table summarizes information relating to outstanding and exercisable warrants as of December 31, 2023: SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants Outstanding and Exercisable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Remaining Contractual life (in years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Valuation as of December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zWvRx4rixJKk" style="width: 22%; text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">8,334</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: center"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zAl7xEMWbTZ5" title="Weighted Average Remaining Contractual life (in years)">2.16</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zx6b887Ck5C3" style="width: 21%; text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.6</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zRqwBSdMPlTb" style="width: 21%; text-align: right" title="Warrants Outstanding and Exercisable, value">23</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zo8wvossphEg" style="text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">32,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zuDgVmDSZIfb" title="Weighted Average Remaining Contractual life (in years)">2.61</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zL66Iz62vgd6" style="text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zAlHFh9oSvTi" style="text-align: right" title="Warrants Outstanding and Exercisable, value">116</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants"><p id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zv4FBGDIk3Tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Warrants Outstanding and Exercisable, Number of Warrants">7,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_znLiIVuPAOd7" title="Weighted Average Remaining Contractual life (in years)">0.46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price"><p id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zea87JQbMrIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.015</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right" title="Warrants Outstanding and Exercisable, value"><p id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_z4Wl7QwI4VBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Warrants Outstanding and Exercisable, value">203,718</td><td style="text-align: left"> </td></tr> </table> The following table summarizes information relating to outstanding warrants as of March 31, 2024: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of Warrants</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Remaining Contractual life (in years)</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Valuation as of March 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zNcV9GqjOvda" style="width: 22%; text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">7,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: center"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zWXVVIClz5Ng" title="Weighted Average Remaining Contractual life (in years)">0.21</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zh6Mu9Dz1Y23" style="width: 21%; text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.01024</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zJfcQJQGIEF9" style="width: 21%; text-align: right" title="Warrants Outstanding and Exercisable, value">71,702</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_ztRgdTkyN1zj" style="text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">8,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zXrNDdXOU0pl" title="Weighted Average Remaining Contractual life (in years)">1.91</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zLeN3PB1z4Mj" style="text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z67tO6AEVN6" style="text-align: right" title="Warrants Outstanding and Exercisable, value">23</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zMC1LEb6Lkv3" style="text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">32,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zclVduwOFncb" title="Weighted Average Remaining Contractual life (in years)">2.36</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zCxQgMMAWLoh" style="text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zpWE4PiikSlf" style="text-align: right" title="Warrants Outstanding and Exercisable, value">116</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_89C_ecustom--ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock_zREh7CC59zjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The estimated fair values of the Warrants were measured according to the data as follows: SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_49D_20240331_zTV5rxkRX28h" style="text-align: center">As of </td><td> </td><td> </td> <td colspan="2" id="xdx_498_20231231_zxtzjH0VzJV6" style="text-align: center">As of </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Expected term</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.21</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.46</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zIenExwlusxi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected average volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">224</td><td style="text-align: left">%</td></tr> <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zd3QgAan6VE1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zBzVEIDou51e" title="Warrants rights outstanding measurement input">4.19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zviGZ5NYVEV4" title="Warrants rights outstanding measurement input">5.3</td><td style="text-align: left">%</td></tr> <tr id="xdx_40E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__custom--MeasurementInputCommonMarketValueMember_z4pablwu953j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Common Stock Market Value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.01024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.015</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__custom--MeasurementInputCommonMarketValueMember_ztK2fs2TD3sf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants rights outstanding measurement input</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.01024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.015</td><td style="text-align: left"> </td></tr> </table> APPYEA INC. NOTES TO THE FINANCIAL STATEMENTS <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in">NOTE 4</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.25in">- </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">CONVERTIBLE LOANS AND WARRANTS (cont.)</td></tr> </table> The Convertible Loans at amortized cost changes consist of the following as of March 31, 2024 and December 31, 2023: SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20240101__20240331_zk5nL8QhKuPc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231_zMIK04rbMW9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">$000</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_400_ecustom--ConvertibleAmortizedCost_iS_zzW3Cl3qG9Ck" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Opening balance</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">796</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--TransitionFromConvertibleLoansMeasuredAtFairValueToMeasurementAtAmortizedCost_zs5FKQqS9Ji9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Transition from convertible loans measured at fair value to measurement at amortized cost</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">530</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_iN_di_zjJEeoUplAkh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Beneficial conversion feature</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(66</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--FinancialExpensesRelatedToTransitionFromFairValueMeasurementToAmortizedCost_zI9ibEip6uHi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Financial expenses related to transition from fair value measurement to amortized cost</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">304</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AccruedInterestInProfitAndLoss_zYWuoUeMhtgb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued interest through profit or loss</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">28</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ConvertibleAmortizedCost_iE_z5j9OmJoT7Vg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Closing balance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">811</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">796</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> <p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_z5JeAUfKj4pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">SCHEDULE OF FAIR VALUE RECURRING BASIS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center">In U.S. dollars</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">None</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z3YrKFhpTcz2" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zwaAAx3DF4yd" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7trzC2JRB62" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ze99KISj0yy7" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; text-align: justify">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify">Convertible Loans At fair value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zcqXDSXaDTNa" style="width: 12%; text-align: right" title="Convertible Loans at fair value">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zscUsVDXmcb1" style="width: 12%; text-align: right" title="Convertible Loans at fair value">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zoqirqVF2wob" style="width: 12%; text-align: right" title="Convertible Loans at fair value">1,203</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7nCEdkkUVHl" style="width: 12%; text-align: right" title="Convertible Loans at fair value">1,203</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Financial liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk51fEkSyo45" style="text-align: right" title="Financial liability">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zYCOYcMdzeuf" style="text-align: right" title="Financial liability">204</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zv1I4MJA1gvj" style="text-align: right" title="Financial liability">204</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">March 31, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center">In U.S. dollars</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-decoration: underline; text-align: justify">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">None</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zt0ayPi0zovb" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIrDieP7rVp" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztthXSfbjVmc" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20240331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIHafEP6pW" style="text-align: right" title="Assets">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; text-align: justify">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: justify">Convertible Loans At fair value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxKhvWZqPXj8" style="width: 12%; text-align: right" title="Convertible Loans at fair value">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zw42LC5svKTg" style="width: 12%; text-align: right" title="Convertible Loans at fair value">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z1QuaVUsoDgi" style="width: 12%; text-align: right" title="Convertible Loans at fair value">2,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20240331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zau1XPMYQmU2" style="width: 12%; text-align: right" title="Convertible Loans at fair value">2,160</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Financial liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztuJQD57wGF4" style="text-align: right" title="Financial liability">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zcgdpuIPuYu2" style="text-align: right" title="Financial liability">72</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_c20240331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2mMyfCpy1Oi" style="text-align: right" title="Financial liability">72</td><td style="text-align: left"> </td></tr> </table> 1203000 1203000 204000 204000 2160000 2160000 72000 72000 SCHEDULE OF CONVERTIBLE LOANS AT FAIR VALUE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20240101__20240331_zE2ROWPgsrLi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20230101__20231231_zK3Umv9W4dD7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Convertible Loans at Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">$000</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40A_eus-gaap--ConvertibleDebt_iS_pn3n3_zKuE8cUSOyLl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Opening Balance, (including short term loans from related party which is also convertible)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">1,203</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">2,257</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium_pn3n3_zYeGQ59OUxV9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additional convertible loans (a)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ConversionOfConvertibleLoan_pn3n3_zg3xfqLem3Nl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Conversion of convertible loan (b)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(243</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--DecreaseOfNotesPurchased_pn3n3_ztlYMdgmacwd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Decrease of notes purchased</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(530</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--ChangeInFairValueOfConvertibleLoansLiabilityThroughProfitOrLoss_iN_pn3n3_di_z9tWyvdzbZvi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of convertible loans liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">957</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(434</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--ConvertibleDebt_iE_pn3n3_zxHPZE3XvQ97" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Closing balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2,160</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,203</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(a)</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the quarter ended March 31, 2024, and the year ended December 31, 2023, the Company raised a principal amount of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_dxL_c20240331_zyac4uYBSbZ2" title="Principal amount::XDX::-">nill and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20231231_za2VkIjVPIj" title="Principal amount">152,750, respectively.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(b)</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">During the quarter ended March 31, 2024, and the year ended December 31, 2023 a total amount of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_dxL_c20240101__20240331_zM492x3KyGNb" title="Converted amount::XDX::-">nill and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230101__20231231_zq1jrRHNYKt4" title="Converted amount">242,538 (which were converted into <span class="xdx_phnt_RGlzY2xvc3VyZSAtIKBTQ0hFRFVMRSBPRiBDT05WRVJUSUJMRSBMT0FOUyBBVCBGQUlSIFZBTFVFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20230101__20231231_zMRKIfvAQMh4" title="Number of shares converted">8,634,616 shares of common stock), respectively.</td></tr></table> 1203000 2257000 153000 -243000 -530000 -957000 434000 2160000 1203000 152750 242538 8634616 <p id="xdx_894_ecustom--ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zYyqMkddjkM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The estimated fair values of the Convertible loans were measured according to the Monte Carlo Model using the following assumptions: SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_493_20240101__20240331_z5vsV9n7sbe5" style="text-align: center">As of </td><td> </td><td> </td> <td colspan="2" id="xdx_492_20230101__20231231_zbvn82XMDoA7" style="text-align: center">As of </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Expected term (in years)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331__us-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zrtPTPS7Y2Q4" title="Expected term (in years)">0.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zvVxsPSQuLTc" title="Expected term (in years)">0.5</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zCgeAY9DSmjf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected average (Monte Carlo) volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">213</td><td style="text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zLiZ5SGoOdXf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zfUYGMmJBLTd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.46</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.26</td><td style="text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--PercentageOfWeightedAverageCostInventory_iE_pid_dp_uPure_hus-gaap--ClassOfWarrantOrRightAxis__custom--OldCLAMember_zfnuLJ2MuNtl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">WACC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27</td><td style="text-align: left">%</td></tr> </table> P0Y3M P0Y6M 0.83 2.13 0.0546 0.0526 0.27 0.27 The following table summarizes information relating to outstanding and exercisable warrants as of December 31, 2023: SUMMARIZES RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants Outstanding and Exercisable</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of Warrants</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Remaining Contractual life (in years)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Valuation as of December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zWvRx4rixJKk" style="width: 22%; text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">8,334</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: center"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zAl7xEMWbTZ5" title="Weighted Average Remaining Contractual life (in years)">2.16</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zx6b887Ck5C3" style="width: 21%; text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.6</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zRqwBSdMPlTb" style="width: 21%; text-align: right" title="Warrants Outstanding and Exercisable, value">23</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zo8wvossphEg" style="text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">32,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zuDgVmDSZIfb" title="Weighted Average Remaining Contractual life (in years)">2.61</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zL66Iz62vgd6" style="text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zAlHFh9oSvTi" style="text-align: right" title="Warrants Outstanding and Exercisable, value">116</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants"><p id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zv4FBGDIk3Tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Warrants Outstanding and Exercisable, Number of Warrants">7,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_znLiIVuPAOd7" title="Weighted Average Remaining Contractual life (in years)">0.46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price"><p id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zea87JQbMrIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.015</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right" title="Warrants Outstanding and Exercisable, value"><p id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_z4Wl7QwI4VBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Warrants Outstanding and Exercisable, value">203,718</td><td style="text-align: left"> </td></tr> </table> The following table summarizes information relating to outstanding warrants as of March 31, 2024: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Number of Warrants</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Remaining Contractual life (in years)</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Valuation as of March 31, 2024</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zNcV9GqjOvda" style="width: 22%; text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">7,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 22%; text-align: center"><span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zWXVVIClz5Ng" title="Weighted Average Remaining Contractual life (in years)">0.21</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zh6Mu9Dz1Y23" style="width: 21%; text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.01024</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantOneMember_zJfcQJQGIEF9" style="width: 21%; text-align: right" title="Warrants Outstanding and Exercisable, value">71,702</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_ztRgdTkyN1zj" style="text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">8,334</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zXrNDdXOU0pl" title="Weighted Average Remaining Contractual life (in years)">1.91</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_zLeN3PB1z4Mj" style="text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantTwoMember_z67tO6AEVN6" style="text-align: right" title="Warrants Outstanding and Exercisable, value">23</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zMC1LEb6Lkv3" style="text-align: right" title="Warrants Outstanding and Exercisable, Number of Warrants">32,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zclVduwOFncb" title="Weighted Average Remaining Contractual life (in years)">2.36</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zCxQgMMAWLoh" style="text-align: right" title="Warrants Outstanding and Exercisable, Weighted Average Exercise Price">0.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240331__us-gaap--StatementEquityComponentsAxis__custom--WarrantThreeMember_zpWE4PiikSlf" style="text-align: right" title="Warrants Outstanding and Exercisable, value">116</td><td style="text-align: left"> </td></tr> </table> 8334 P2Y1M28D 0.6 23000 32500 P2Y7M9D 0.6 116000 7000000 P0Y5M15D 0.015 203718000 7000000 P0Y2M15D 0.01024 71702000 8334 P1Y10M28D 0.6 23000 32500 P2Y4M9D 0.6 116000 <p id="xdx_89C_ecustom--ScheduleOfFairValuesOfWarrantsAndConvertibleLoanAssumptionUsedTableTextBlock_zREh7CC59zjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The estimated fair values of the Warrants were measured according to the data as follows: SCHEDULE OF FAIR VALUES OF WARRANTS AND CONVERTIBLE LOAN ASSUMPTION USED <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_49D_20240331_zTV5rxkRX28h" style="text-align: center">As of </td><td> </td><td> </td> <td colspan="2" id="xdx_498_20231231_zxtzjH0VzJV6" style="text-align: center">As of </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">March 31, 2024</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Expected term</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.21</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">0.46</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zIenExwlusxi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected average volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">224</td><td style="text-align: left">%</td></tr> <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zd3QgAan6VE1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zBzVEIDou51e" title="Warrants rights outstanding measurement input">4.19</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zviGZ5NYVEV4" title="Warrants rights outstanding measurement input">5.3</td><td style="text-align: left">%</td></tr> <tr id="xdx_40E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__custom--MeasurementInputCommonMarketValueMember_z4pablwu953j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Common Stock Market Value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.01024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.015</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__custom--MeasurementInputCommonMarketValueMember_ztK2fs2TD3sf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants rights outstanding measurement input</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.01024</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.015</td><td style="text-align: left"> </td></tr> </table> P0Y2M15D P0Y5M15D 87 224 4.19 5.3 0.01024 0.015 0.01024 0.015 The Convertible Loans at amortized cost changes consist of the following as of March 31, 2024 and December 31, 2023: SCHEDULE OF CONVERTIBLE LOANS AMORTIZED COST <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 89%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20240101__20240331_zk5nL8QhKuPc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">March 31, 2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20230101__20231231_zMIK04rbMW9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">$000</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_400_ecustom--ConvertibleAmortizedCost_iS_zzW3Cl3qG9Ck" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Opening balance</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">796</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--TransitionFromConvertibleLoansMeasuredAtFairValueToMeasurementAtAmortizedCost_zs5FKQqS9Ji9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Transition from convertible loans measured at fair value to measurement at amortized cost</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">530</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_iN_di_zjJEeoUplAkh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Beneficial conversion feature</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(66</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--FinancialExpensesRelatedToTransitionFromFairValueMeasurementToAmortizedCost_zI9ibEip6uHi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Financial expenses related to transition from fair value measurement to amortized cost</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">304</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--AccruedInterestInProfitAndLoss_zYWuoUeMhtgb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued interest through profit or loss</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">28</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--ConvertibleAmortizedCost_iE_z5j9OmJoT7Vg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Closing balance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">811</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">796</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> 796000 530000 66000 304000 15000 28000 811000 796000 NOTE 5 - STOCK BASED COMPENSATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt">A.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The table below depicts the number of options granted to employees and service providers:</td></tr></table> <p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zYPCCOEfqV26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"> SCHEDULE OF NUMBER OF OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted average exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">in USD</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Options outstanding at January 1, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zF9eZRnCHsAg" style="width: 16%; text-align: right" title="Number of options, Outstanding balance">62,349,647</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zjhApaxmyqWi" style="width: 16%; text-align: right" title="Weighted average exercise price, Outstanding balance">0.0007</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Options granted during the period</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zUfWlidU81v8" style="padding-bottom: 1.5pt; text-align: right" title="Number of options, Granted">7,900,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zFJDLBQR73Mk" style="padding-bottom: 1.5pt; text-align: right" title="Weighted average exercise price, Granted">0.00373</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options exercised during the period*</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_fKg_____ze6FmmdLEcHb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, Exercised">(500,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_fKg_____zrZ1K1sGtrc5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, Exercised"> 0.0001</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Options outstanding at the end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zKYxGWMn7k7f" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, Outstanding balance">69,749,647</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zniY3bGFSu3d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Outstanding balance">0.00107</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Options exercisable at the end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zV4yTVpeZtPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, Exercisable balance">25,650,311</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zu9qEUKDWxca" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable balance">0.00136</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F01_z87VakhUnH32" style="width: 35pt; text-align: right">*</td><td style="text-align: justify">A board member exercised his options into shares during the quarter</td> </tr></table> For the three months ended March 31, 2024 and 2023 the company recognized expenses, to such options, in the amount of $147,000 and $279,000, respectively. The expense is non-cash stock-based compensation expense resulting from options awards to the Chief Executive Officer, Chief Financial Officer and advisors The expense represents the aggregate grant date fair value for the option awards granted and vested during the fiscal years presented, determined in accordance with FASB ASC Topic 718. APPYEA INC. NOTES TO THE FINANCIAL STATEMENTS <p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zYPCCOEfqV26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"> SCHEDULE OF NUMBER OF OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 86%; margin-left: 1in"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months ended March 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted average exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">in USD</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Options outstanding at January 1, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zF9eZRnCHsAg" style="width: 16%; text-align: right" title="Number of options, Outstanding balance">62,349,647</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zjhApaxmyqWi" style="width: 16%; text-align: right" title="Weighted average exercise price, Outstanding balance">0.0007</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Options granted during the period</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zUfWlidU81v8" style="padding-bottom: 1.5pt; text-align: right" title="Number of options, Granted">7,900,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zFJDLBQR73Mk" style="padding-bottom: 1.5pt; text-align: right" title="Weighted average exercise price, Granted">0.00373</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Options exercised during the period*</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_fKg_____ze6FmmdLEcHb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, Exercised">(500,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_fKg_____zrZ1K1sGtrc5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, Exercised"> 0.0001</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Options outstanding at the end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zKYxGWMn7k7f" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, Outstanding balance">69,749,647</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zniY3bGFSu3d" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Outstanding balance">0.00107</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Options exercisable at the end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zV4yTVpeZtPh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, Exercisable balance">25,650,311</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ConsultantsAndEmployeesMember_zu9qEUKDWxca" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable balance">0.00136</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F01_z87VakhUnH32" style="width: 35pt; text-align: right">*</td><td style="text-align: justify">A board member exercised his options into shares during the quarter</td> </tr></table> 62349647 0.0007 7900000 0.00373 500000 0.0001 69749647 0.00107 25650311 0.00136 147000 279000 NOTE 6 - SIGNIFICANT EVENTS DURING THE PERIOD <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">A.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On January 1, 2024, the Company engaged with a consultant. For his services he was granted stock option to purchase 2,300,000 of the Company’s Common Stock, valued at $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_pid_c20240101__20240101__srt--TitleOfIndividualAxis__custom--ConsultantMember_zR4cucdxaMtb" title="Stock option granted, value">34,350. <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20240101__20240101__srt--TitleOfIndividualAxis__custom--ConsultantMember_z5qFO0I7lCeh" title="Option vesting description">The Options are vested on a monthly basis, over a period of 30 months as of the commencement date ending June 30, 2026. The options are exercisable at a per share exercise price of $0.01 and are otherwise subject to the other terms and conditions specified in an Option Grant Agreement to be entered into between optionee and the Company.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">B.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On January 1, 2024, the Company engaged with an additional consultant. For his services, he was granted a stock option to purchase <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_pid_c20240101__20240101__srt--TitleOfIndividualAxis__custom--ConsultantOneMember_zz5piLQbuqE5" title="Stock option granted">600,000 of the Company’s Common Stock, valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_pid_c20240101__20240101__srt--TitleOfIndividualAxis__custom--ConsultantOneMember_zZmUnp0mhPY8" title="Stock option granted, value">8,961. <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20240101__20240101__srt--TitleOfIndividualAxis__custom--ConsultantOneMember_zhyUfAGtmeXd" title="Option vesting description">The Options are vested on a monthly basis, over a period of 30 months as of the Commencement Date ending June 30, 2026. The Option are exercisable at a per share exercise price of $0.01 and are otherwise subject to the other terms and conditions specified in an Option Grant Agreement to be entered into between optionee and the Company.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">C.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On January 1, 2024, the Company engaged with a note holder as a consultant. For his services, he was granted a stock option to purchase 5,000,000 of the Company’s Common Stock, valued at $74,675. <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20240101__20240101__srt--TitleOfIndividualAxis__custom--ConsultantTwoMember_zGeEE5G5nH94" title="Option vesting description">Upon grant, the Options vest on a monthly basis, over a period of 12 months as of the Commencement Date ending December 31, 2024. The Option are exercisable at a per share exercise price of $0.0001.</td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif">D.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> During the first quarter of 2024, the company received an additional investment of $456,431 and registered shares to be issued from that investment in the amount of 7,500,000 common shares.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif">E.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On August 11, 2022, a lawsuit was filed in the Tel Aviv Magistrate’s Court against our Chairman and majority shareholder, Boris Molchadsky, G.P.I.S Ltd., an entity controlled by Mr. Molchadsky, Nexsense, Inc. (the former shareholder of SleepX Ltd.) and SleepX, Ltd., our subsidiary (collectively, the “Defendants”) [Civil lawsuit number 25441-08-22]. The suit was filed by a fund operating out of Israel. A copy of the claim was served to the defendants only six months after it was submitted to court, on February 21, 2023. The lawsuit is based on the alleged breach of partnership and loan agreements as well as other related allegations, including violation of agreements reached in a mediation proceeding that took place in 2015. On July 24, 2023, the Defendants (except for Nexsense, Inc.) filed a statement of defense, denying the allegations and argued that the claim should be dismissed, due to the statute of limitations, lack of cause of action, lack of jurisdiction, delay in filing the claim, and respecting SleepX, also due to the lack of legal rivalry between SleepX and the plaintiff. Recently, the Magistrate’s Court in Tel Aviv accepted the request regarding lack of material jurisdiction, and the claim was then transferred to the economic department of the District Court in Tel Aviv. A preliminary hearing was held on February 14, 2024. The presiding judge did not rule on the preliminary pleadings and urged the parties to attempt mediation before the ruling. The parties are considering different mediators (which must be mutually agreed to) and following the selection of a mediator, the parties will schedule a date for the mediation. The Company cannot, at this stage, know the effects, if any, of these actions on its subsidiary SleepX and / or the Company, and accordingly, no provision was recorded. </td></tr> </table> 2300000 34350 The Options are vested on a monthly basis, over a period of 30 months as of the commencement date ending June 30, 2026. The options are exercisable at a per share exercise price of $0.01 0.01 600000 8961 The Options are vested on a monthly basis, over a period of 30 months as of the Commencement Date ending June 30, 2026. The Option are exercisable at a per share exercise price of $0.01 0.01 5000000 74675 Upon grant, the Options vest on a monthly basis, over a period of 12 months as of the Commencement Date ending December 31, 2024. The Option are exercisable at a per share exercise price of $0.0001. 0.0001 456431 7500000 NOTE 7 - SUBSEQUENT EVENTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">A.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On May 13, 2024, Mr. Neil Kline announced the company on his resignation from the board of directors of the company. In Parallel, Mr. Kline signed an advisor agreement with the company to serve as an advisor of the Board, and provide services related to the development of company future products, creating marketing tools for company needs, and assist with filings and projects of the company. </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">B.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On May 14, 2024, the Board of the Company (the “Boad”) approved the conversion of outstanding amounts owed to its officers and directors for unpaid compensation for options of the Company’s common stock, as follows: Boris Molchadsky, the Company chairman, and Asaf Porat, the Company CFO, agreed to convert a portion their unpaid compensation into options for shares of the Company’s common stock at a per share conversion rate of $<span id="xdx_902_ecustom--CommonStockConvertibleConversionPrice_iI_pid_c20240514__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--BorisMolchadskyMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zg3FeQNvNcma" title="Share conversion rate">0.07 and $<span id="xdx_90D_ecustom--CommonStockConvertibleConversionPrice_iI_pid_c20240514__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--AsafPoratMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaIZzBtV9GYh" title="Share conversion rate">0.04, respectively, and Adi Shemer, the Company CEO, has agreed to convert the entire unpaid compensation to him into options for shares of the Company’s common stock at per share conversation date of $<span id="xdx_90D_ecustom--CommonStockConvertibleConversionPrice_iI_pid_c20240514__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--AdiShemerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3zr3bkiGrhd" title="Share conversion rate">0.04, in each case under a Company compensation Plan to be approved by the Company and its shareholders and qualified under Sections 102 and 103 of the Israeli tax authorities (such being the “Qualified Equity Interests”). There remains outstanding unpaid compensation to each of Mr. Molchadsky and Porat in the amount of $<span id="xdx_902_ecustom--OutstandingUnpaidCompensation_c20240514__20240514__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--BorisMolchadskyMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zEbKCvRwdoc8" title="Outstanding unpaid compensation">70,000 and $<span id="xdx_902_ecustom--OutstandingUnpaidCompensation_c20240514__20240514__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--AsafPoratMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5iIioCDqUB3" title="Outstanding unpaid compensation">50,000, respectively. It was agreed that the unpaid compensation which was not converted would be paid in 20 equal monthly instalments, subject to payment of payroll, social security and other taxes, commencing on the 30th day following the earlier to occur of (i) the closing of an equity raise by the Company with proceeds to the Company of at least $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240514__20240514__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQzadprMbaIk" title="Proceeds from issuance of common stock">1.5 million, (ii) the completion of seven consecutive (7) months positive cash flow for the Company in such amount as will allow the Company to cover its operating expenses and (iii) termination of employment by the Company of for any reason other than cause. As of April 1, 2024 the Company converted the outstanding amounts related to its officers and directors and issued <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20240401__srt--TitleOfIndividualAxis__custom--OfficerAndDirectorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z8grwbpKzYz4" title="Options outstanding">6,959,692 options, which are exercisable with an exercise ratio of 1:1.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">C.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In addition, the Board approved the issuance of stock option to purchase <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20240701__srt--TitleOfIndividualAxis__custom--AdiShemerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJO5r6Vs1X5l" title="Number of shares issued">6,000,000 shares of the Company’s common stock, at a per share exercise price of $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20240701__srt--TitleOfIndividualAxis__custom--AdiShemerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWJK5b0uZ978" title="Common stock exercise price">0.0001, to Adi Shemer, the Company CEO. Under his terms of his employment agreement, Mr. Shemer is entitled to these options following the issuance by the Company of at least <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pn6n6_c20240701__20240701__srt--TitleOfIndividualAxis__custom--AdiShemerMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MinimumMember_zygMAtkx3Lbl" title="Number of shares issued">100 million shares of common stock in respect of third-party investments in the Company, which was satisfied in February 2024. The options will vest in full on July 1, 2024. For the three-month ended March 31, 2024 the Company recorded an expense related to the issuance of $49,492 out of a total expense of $197,966.</td></tr> </table> 0.07 0.04 0.04 70000000 50000000 1500000 6959692 6000000 0.0001 100000000 49492 197966 false false false false During the quarter ended March 31, 2024, and the year ended December 31, 2023, the Company raised a principal amount of nill and $152,750, respectively. During the quarter ended March 31, 2024, and the year ended December 31, 2023 a total amount of nill and $242,538 (which were converted into 8,634,616 shares of common stock), respectively. A board member exercised his options into shares during the quarter